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Background: Despite advancements in surgical techniques through the use of robotic 
assisted radical prostatectomy, urinary incontinence remains the most common side effect 
following surgery affecting men s quality of life. 
Objective: To explore the role of a single pre-operative pelvic floor muscle training 
session. To determine if men who receive the training session have a decrease incidence 
of incontinence post-op, whether pelvic floor muscle strength pre-operatively is an 
independent predictor of urinary incontinence, and the impact of incontinence on quality 
of life in men following a robotic-assisted radical prostatectomy in the early stages post-
operatively. 
Design: A two part study with a retrospective portion and a prospective pilot cohort 
study. 
Method: Electronic medical record review of 140 men who have undergone robotic 
assisted radical prostatectomy was conducted for the retrospective study.  For the 
prospective study, twenty consecutive patients who underwent robotic assisted radical 
prostatectomy were randomized into 2 groups, the intervention group received the pelvic 
floor muscle training and the control group did not.  Outcome measures included pelvic 
floor muscle strength, 24 hour pad test, and quality of life instruments. 
Results: Urinary incontinence was significantly less at 6 weeks post-op with one session 
of pre-op pelvic floor muscle training.  None of the demographics and PF muscle 
performance pre-op, with the exception of race, related to incontinence post-op.  The 
pelvic floor muscle training session alone was related to improved continence post-op.  
Pelvic floor muscle strength (p = .038) and endurance (p <.001) improved over time and 
iv 
 
more rapidly in the pelvic floor muscle training group with coinciding diminished 
severity of incontinence.  Functional impact of incontinence decreases over time in both 
groups with a significantly lesser impact in the PFMT group (IIQ-7, p = .008, UCLA, p 
<.001). The impact in the PFMT group at 6 weeks was less than at 3 months in the 
control group. 
Conclusions:  The results of this study indicate that a single, pre-operative pelvic floor 
muscle training session may improve early continence and quality of life outcomes after 
robotic assisted radical prostatectomy. Larger scale studies should be conducted to 
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                                              CHAPTER 1: INTRODUCTION 
OVERVIEW 
Prostate carcinoma (CA) has been the second leading cause of death in men in America 
for decades. Since the implementation in 1988 of an annual Prostate-Specific Antigen 
(PSA) and Digital Rectal Examination (DRE) screening, more men are being diagnosed 
with the condition (up to 15%) and are being diagnosed at an early age (average of 66 
years old).1,2  The available treatments for prostate CA, include: watchful waiting, 
cryosurgery, radiation, chemotherapy, hormone therapy, vaccine treatment, bone-directed 
treatment, and surgery for radical prostatectomy.2 Prostatectomy remains the treatment of 
choice and may be performed through a number of approaches: traditional open 
approach, retropubic or perineal, laparoscopic, or more recently, through the da Vinci 
robotic procedure.  The robotic procedure has gained popularity amongst surgeons as the 
system provides more maneuverability and more precision when moving the instruments 
than the standard laparoscopic approach and decreased blood loss is associated with the 
more minimally invasive technique. The extent of the procedures is dictated by the level 
of the Gleason score and pathology stage of the CA. The risks in all procedures result 
from the degree of the damage rendered to the surrounding peritoneal fascia, bladder 
neck, and neurovascular bundle (NVB).  The techniques gear to preserve or reconstruct 
those structures peri-operatively, therefore lower the chances of side effects.3-10  The most 
common side effects of all procedures are impotence (e.g, erectile dysfunction, changes 
in orgasm, penis length, loss of fertility) and urinary incontinence (e.g, stress, urge, 
overflow or continuous).  Even with the precision of the robotic assisted prostatectomy, 
none of the approaches differ in terms of side effects.2,11-17  As many as 87% of men may 
2 
 
experience incontinence immediately following prostatectomy1,2,18 and the likelihood of 
its occurrence increases with age,19-23 thus impacting one s quality of life. 
This research explored the role of a pre-operative pelvic floor muscle training (PFMT) 
session, and whether pelvic floor (PF) muscle strength pre-operatively is a predictor of 
urinary incontinence and the impact of incontinence on quality of life in men following a 
robotic-assisted radical prostatectomy in the early stages post-operatively. 
PROBLEM STATEMENT AND GOAL 
Multiple systematic reviews have concluded to the benefits of PFMT in reducing the 
incidence of incontinence in females after giving birth and/or following uro-
gynecological interventions.24-27 Recently, studies have also shown the same benefits in 
addressing post-prostatectomy incontinence in men in the short-term28-47 but the long-
term benefits have been inconclusive from the results of a number of systematic 
reviews.48,49 Two studies have correlated PF muscle weakness to the incidence of 
incontinence following a radical prostatectomy.50,51 The study by Ocampo-Trujillo et al52 
shows histologic PF muscle changes with a pre-operative PFMT program. The rationale 
of PFMT, which focuses on building strength, endurance, speed and coordination of the 
PF muscles in various situations, is that it improves PF tone and organ support, thereby 
reducing the symptoms of incontinence.50 However, only a few studies discuss the 
benefits of a pre-operative PFMT session in reducing the severity and period of 
incontinence post-operative53-56while others show no benefit.57,58  
Physical therapists who specialize in the treatment of PF muscle dysfunction are 
positioned in a role of expert clinicians in the assessment of PF strength and the 
management of urinary incontinence.  There are a variety of ways to assess PF strength.  
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The most commonly used tools or techniques used by physical therapists are digital 
palpation, perineometer, sEMG, the Laycock modified Oxford grading system (0-5 point 
scale) and the PERFECT scheme.59,60,61 
This study explored the effect of receiving a one-time pre-operative PFMT on the 
occurrence of post-operative urinary incontinence and the impact on quality of life in 
men following a da Vinci robotic-assisted radical prostatectomy.  It was hypothesized 
that with improved PF awareness and strength, patients who received the PFMT session 
pre-operatively would not suffer from incontinence to the degree and length of time post-
operatively as those patients who did not receive the pre-operative training.  The benefits 
would occur regardless of the pre-operative PF muscle strength, patient s age, Gleason 
score, T-stage, or NVB preservation 
RELEVANCE AND SIGNIFICANCE 
There are some conflicting thoughts on the long term benefits of PFMT in the treatment 
of incontinence for men following a robotic-assisted prostatectomy, as well as in the 
benefits of pre-operative PFMT in the prevention of post-operative urinary incontinence.  
However, there is value if PFMT could aid those patients to improve their quality of life 
through decreased severity and period of post-operative urinary incontinence 
immediately following surgery.  Improving one s awareness of PF muscles and 
improving the PF strength prior to prostatectomy could potentially improve organ support 
and improve the ability to constrict the urinary flow in the urethra during functional 
activities, thus decreasing the chance of incidence of urinary incontinence.41-44 The 
improved continence  would save on the cost that could result from dealing with 
incontinence post-operatively, such as having to use pads, prolonged use of physical 
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therapy services post-operatively when the PF muscles have been damaged, and possible 
need for further more invasive interventions (such as injection of urethral bulking agents, 
use of clamps, sub-urethral slings, or artificial urinary sphincter implantation).30,62,63 
RESEARCH QUESTIONS 
Therefore, this research proposed two phases to answer the following questions: 
Phase one was a retrospective study: 
1. Do men who receive a one-time pre-op PFMT have less incontinence 
following the robotic assisted daVinci prostatectomy than men who do not?  
2. What are the differences in PF muscle strength and demographic variables 
between patients with more vs. fewer incidence of urinary incontinence? 
Phase two was a prospective randomized pilot study:  
3. Do men who present with the associating factors identified in the retrospective 
study have less symptoms of incontinence following the robotic assisted 
daVinci prostatectomy vs. those who do not? 
4. Do men who have received the one-time pre-op PFMT session present with 
improved PF strength, less incontinence, and better quality of life scores in the 
early stages following the robotic assisted daVinci prostatectomy compared to 
those who did not? 
APPROACH 
This research consisted of two parts.  The first part was a retrospective study.  After 
appropriate Nova Southeastern University IRB approval was received; data was collected 
from electronic chart reviews of patients who have undergone a da Vinci robotic 
prostatectomy, with and without completion of a one-time pre-operative PFMT session.  
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Data was retrieved from both the physicians  and the physical therapists  records taken 
from their medical history and their respective physical examinations.  The pre-operative 
demographic information was recorded, including: age, ethnicity, level of education, 
symptoms if any, and stage of prostate CA (Gleason score and clinical T-stage).  Intra-
operative factors, such as bladder neck and neurovascular bundle preservation were also 
noted, as well as PF strength and endurance from those patients who have received the 
one-time pre-operative PFMT by the physical therapist.  Post-operative information was 
collected at 3 points in time: at the post-op follow-up appointments with the surgeon at 6 
weeks, 3 months, and one year following the prostatectomy.  Post-operative information 
included incidence and level of urinary incontinence through use and changes of 
pads/day. Additional information was also gathered, such as other post-operative 
complications, need of post-operative physical therapy, or whether further intervention 
was recommended or performed.   
The second portion was a small cohort prospective study.  Data was collected pre-
operatively and post-operatively at 6 weeks and 3 months from a small sample of 
convenience of 20 patients who had undergone the da Vinci prostatectomy.  The subjects 
were randomly assigned into 2 groups, one received the one-time pre-operative PFMT 
session and the other did not.  Outcome measures included degree of incontinence 
(number of pads/day), PF strength (power and endurance), and measures of QoL (IIQ-7 
and UCLA-PCI functional questionnaires) (Appendix H-I) 
Statistical analysis included descriptive statistics, t-tests and Chi-square tests for 
demographic comparisons.   For the retrospective study, the Chi-square test was used to 
compare incontinence and the Mann-Whitney test was used to compare the severity of 
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incontinence between the 2 groups at the 3 points of time.  Each factor was evaluated 
using the Chi-square (categorical variables), t-test (normally distributed continuous 
variables), or Mann-Whitney (non-normally distributed continuous variables) test to 
assess its association with less incontinence post-operatively in both the retrospective and 
prospective study.  For the cohort study, the variables were further analyzed as a function 
of time post-op and PFMT condition in a 3X2 mixed-model Analysis of Variance 
(ANOVA).  For the variables without a pre-op value, a 2X2 mixed-model ANOVA was 
used. 
OPERATIONAL DEFINITION OF TERMS 
The following definitions are provided to ensure uniformity and understanding of these 
terms throughout the study.   
Incontinence-involuntary leakage of urine from the bladder.  
Intra-operative-occurring, carried out, or encountered during the course of surgery. 
PERFECT scheme-Power Endurance Repetitions Fast Every Contraction Timed  
 grading scale to manually assess the pelvic floor muscle strength and endurance,        
 using the Oxford scale for the measure of power, number of seconds of   
 contraction held for endurance, number of repetitions of the contractions.62 
Peri-operative-relating to, occurring in, or being the period around the time of a  
      surgical operation.   
Post-operative-relating to, occurring in, or being the period following a surgical  
      operation.   
 
Pre-operative-occurring, performed, or administered before and usually close to a 
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       surgical operation.  
Quality of Life- the impact of incontinence on quality of life was measured by 2 
      condition-specific functional assessment questionnaires: the IIQ-7 and UCLA- 
      PCI 
sEMG-surface electromyography, the electrical activity of individual muscles or 
      muscle groups is detected and amplified through non-invasive electrodes. 
SUMMARY 
Prostatectomy remains the treatment of choice to address the presence of prostate CA in 
men2.  Recently the use of the da Vinci robotic-assisted prostatectomy has become 
increasingly popular with surgeons.  Despite the technological advances, there has not 
been an associated improvement in post-operative complications, with the most common 
complication being that of urinary incontinence.  A PFMT program may aid in the 
recovery of post-operative continence if performed pre-operatively, before the peritoneal 
tissues have been damaged.  Therefore, this research proposed to identify if a one-time 
pre-operative PFMT session aids in limiting the severity and duration of post-operative 
incontinence and its effect on quality of life.   









  CHAPTER 2: LITERATURE REVIEW 
INTRODUCTION 
Incontinence following a robotic-assisted radical prostatectomy (RARP) remains as one 
of the most common post-operative complications affecting ones  quality of life 
immediately following surgery.2,12-18 Several factors may influence the occurrence and 
severity of post-operative incontinence.  Being able to predict these factors may aid in the 
treatment decision making process for both the patient and the surgeon through offering 
counseling in individualized expected outcomes.  Furthermore, identifying the factors 
that result in increased severity of incontinence post-operatively may allow for earlier 
intervention such as biofeedback and PFMT that may enhance the likelihood of recovery 
of continence after the procedure.  The following review of selected studies in the field 
highlights findings most influential in the development of more advanced surgical 
procedures as well as pre-operative, peri-operative, and post-operative events that may 
aid in preventing the occurrence of urinary incontinence post-operatively.  The review is 
organized according to historical events, predictors of the occurrence of urinary 
incontinence post-operatively, and research pertaining to the use of PFMT to address 
incontinence in men following a prostatectomy. 
THE DA VINCI ROBOTIC ASSISTED PROSTATECTOMY 
Instrumentation 
Laparoscopic surgery for the treatment of prostate CA has been gradually replacing the 
more commonly used open retro-pubic approach since the 1990s.  However, even though 
this minimally invasive technique results in less morbidity (decreased blood loss and 
rates of transfusion), the use of the conventional instrumentation remains complex, 
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demanding extensive knowledge in the topographical anatomy and proficiency with 
endoscopic suturing and intra-corporeal knot tying, which is required in a laparoscopic 
radical prostatectomy.  The advent of the da Vinci RARP in the early year 2000 s in 
America provides for a simpler and more enabling endoscopic technique. The daVinci 
Surgical System (Intuitive Surgical, Inc., Sunnyvale,CA, USA) incorporates three robotic 
arms, one holding a novel dual channel endoscope and two holding the endoscopic 
instruments, which are controlled through manipulation of two master controls mounted 
on the surgeon s console, where the surgeon sits and operates during the procedure. 
Surgeon manipulation of the controls is managed by a processor that filters, scales and 
relays the exact motion of the surgeon s hands and fingers to the endoscopic instruments. 
There is no measurable delay between movement of the surgeon controls and the 
mirrored movement of the instruments. Tremors and minor insignificant movements of 
the surgeon that are commonly encountered while holding instruments, particularly 
during protracted procedures, are eliminated by the processor. The integrated architecture 
of the instruments and system allow 7 degrees of freedom which is more than allowed by 
the human hand. The two images of the dual channel endoscope are fused providing the 
surgeon with a magnified, resolute stereovision image of the operative field.  The 
magnification and manual dexterity offered by the robot allows a higher level of attention 
to detail and resultant precision in surgery.  
Outcomes                    
It has been suggested that surgical techniques sufficiently refined to preserve or 
reconstruct the perineal structures peri-operatively would lower the chances of side 
effects.4-11 Since the advent of the RARP procedure, studies have been conducted to 
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compare the outcomes between the various surgical procedures in an attempt to identify a 
superior technique.  The outcomes measured included those of positive surgical margins 
and PSA levels as well as physical and mental functioning, urinary continence, potency, 
and quality of life.  All have come to the same conclusion: despite the improved 
microsurgical precision offered by the RARP to preserve the integrity of the PF 
structures, the functional and oncological outcomes remain similar between the 
techniques11-17.  However, the RARP does offer the benefits of a minimally invasive 
technique notably that of decreased blood loss and transfusion rates, decreased post-
operative pain, shorter convalescence, and better cosmetics.11,14-17,64-67 Thus, urinary 
incontinence remains the main post-operative complication affecting men following a 
daVinci RARP and it has therefore become important to attempt to identify the factors 
that may influence its occurrence.   
Types of incontinence 
There are different types of urinary incontinence, including stress, urgency, or mixed.  
Stress urinary incontinence refers to the involuntary loss of urine with physical exertion 
that is the result of anatomical defects in the structures that support the bladder and 
urethra, while urgency urinary incontinence is associated with the involuntary loss of 
urine due to a sudden compelling need to void that is due to the contraction of the 
detrusor muscle, and mixed urinary incontinence presents with signs of both stress and 
urgency urinary incontinence. The type of urinary incontinence most commonly found in 
men following a prostatectomy is that of stress urinary incontinence.68,69The degree of 
incontinence can range from mild to severe, where men experience the loss of urine with 
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changes of positions such as sitting from lying, or standing from sitting, coughing, during 
physical activities such as lifting or bending, or even at rest.   
RISK FACTORS OF INCONTINENCE 
Long term 
Most studies that have been conducted to identify the factors that predict recovery of 
continence long-term, have primarily looked at age and surgical procedures.  In a large 
scale study that included functional questionnaires, Shikanov et al70 reported on 1436 
patients who underwent RARP and found that younger age (<70) and higher urinary and 
sexual function pre-surgically were associated with continence at 1 year post-surgically.  
A similar analysis by Barnoiv et al19 found in addition that prostate volume, nerve 
sparing status, and 24 hour urine loss at 1 month post-operatively also predict the risk of 
urinary incontinence at 1 year with good accuracy.  Choi et al4 studied the same factors as 
well as bladder neck sparing and found that bilateral nerve sparing and bladder neck 
sparing techniques, and higher urinary function pre-operatively resulted in improved 
urinary control up to 2 years post-operatively. On a smaller scale, Hakimi et al71 assessed 
anatomical measurements through endorectal MRI on 75 patients and found that longer 
urethral length, as well as younger age, lower BMI, higher pre-operative urinary function, 
and smaller prostate volume correlated to a faster return of continence.  Kaye et al6 
further assessed the effect of nerve sparing on quality of life and found better outcomes at 
12 months with uni- or bilateral nerve sparing, younger age and lower BMI. Conversely, 
in another large study that assessed the functional outcome of both open procedure and 
RARP, Nilsson et al72 did not find that BMI, prostate weight, or comorbidities had an 
effect on the prevalence of urinary incontinence at a 2 year follow-up. While Novara et 
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al73 agree that no variables related to prostate CA correlated with urinary incontinence in 
their study, they did find that age and comorbidity index were factors independently 
predictive of continence recovery at 1 year post-operatively. 
Short term 
Urinary incontinence usually resolves naturally by the end of the first year following any 
type of prostatectomy, with individual studies reporting up to 97% continence rate after 
RARP.48,49  Therefore, it would seem more advantageous to identify predictors geared at 
shortening the time to recovery of continence following RARP. Only a small number of 
studies have been done to examine the factors that may predict recovery within 3 months, 
especially after RARP.  A small study by Potdevin et al8 compared the inter- and intra-
facial nerve sparing techniques on functional and oncological outcomes and found that 
the intra-facial technique improved potency rate and shortened the time to return of 
continence, however to the detriment of higher rates of positive surgical margins.  A 
much larger study by Srivastava et al74 also found early return of continence with no pad 
use at 12 weeks when a higher degree of nerve sparing technique was used.  In a 
retrospective study,  Kim et al75 identified that age (<70), higher pre-operative sexual 
health, lower clinical T-stage, lower Gleason score, shorter operative time, lower blood 
loss, and smaller prostate volume are all associated with urinary recovery within 3 
months.  However, in a large prospective study on 1299 patients from a high volume 
center, Ko et al20 demonstrated that only age and nerve sparing were factors for 
continence by 3 months.  Lee et al22 found that only age was associated with early 
recovery of continence at 6 weeks after adjusting for confounding factors in a 
multivariate logistic model, but the study was small with limited factors (BMI, IPSS 
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score, nerve sparing).  In a large restrospective study spanning over 10 years (from 2003 
to 2013),  Palisaar et al76 analyzed predictors of short-term recovery of continence at 6 
weeks in both the open and RARP.  The multivariate results showed that nerve sparing, 
clinical T-stage, the surgeon s experience, and duration of catheri ation were all 
independent factors.  A recent research conducted by Lavigueur-Blouin et al21 observed 
pre-operative predictors of pad-free continence recovery at the first follow-up visit one 
month after RARP and reported a rate of 44% pad-free patients.  In their multivariate 
regression analysis, age and ICIQ (International Consultation on Incontinence 
Questionnaire) were the independent predictors of urinary continence at one month.  
Other variables, including BMI, PSA, SHIM (Sexual Health Inventory for Men) score, 
prostate weight, and type of nerve sparing were not statistically significant predictors of 
very early continence.  By contrast, in a large study of more than 1200 patients followed 
retrospectively, Sammon et al77 concluded that bilateral nerve sparing and the placement 
of a supra-pubic tube for bladder drainage were predictors of not requiring a pad 
immediately post-operatively.   
Finally, even though some studies seem to contradict each other, a consensus panel78 was 
conducted in 2012, and following systematic reviews and a meta-analysis, concluded that 
the following factors that generally contribute to increased risk of post- RARP 
incontinence are: age, obesity, short membranous urethral length, anastomotic strictures, 
low surgeon experience, non-nerve sparing techniques, non-bladder neck preservation, 
and high prostate volume.  
All the aforementioned studies have been able to identify patient characteristics and 
procedural techniques as predicting factors to the incidence of urinary incontinence post-
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operatively.  None have looked at PF strength as a possible factor.  One of the aims of 
this study is to identify whether PF strength is a predictor and whether improved strength 
results in improved continence immediately post-operatively.  
PELVIC FLOOR   
Anatomy 
A recent research report conducted by Gorniak and Conrad79 has compiled the 
descriptions in the literature with dissections to re-examine the anatomy and functional 
interactions of the muscles of the pelvic floor, as well as the endopelvic and visceral 
support structures.  The diamond-shaped perineum is bound anteriorly by the pubic 
symphysis, posteriorly by the tip of the coccyx, laterally by the pubic arch, ischial 
tuberosities, and sacrotuberous ligaments, and cranially by the pelvic diaphragm (Figure 
2.1). The pelvic diaphragm is part of the pelvic floor musculature and consists of the 
levator ani (formed by the pubococcygeus and the iliococcygeus) and the coccygeus 
muscles, and provides support for the pelvic viscera. The superficial and deep transverse 
perineal muscles, bulbospongiosus, levator prostate, and outer layer of the external anal 
sphincter attach to the perineal body which is centrally located.  The perineum is 
generally divided into a posterior anal triangle and an anterior urogenital triangle by a 
line passing through the ischial tuberosities and the perineal body (Figure 2.2). The anal 
triangle is bordered laterally by the obturator internus muscle and its fascia connecting to 
the levator ani through the tendinous arch which runs from the pubic body to the ischial 
spines and is formed by fibers of both muscles.  The inferior part of the obturator internus 
fascia splits to form the pudendal canal through which the pudendal nerve and internal 
pudendal artery and vein runs through. The urogenital triangle is further divided into the 
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superficial and deep perineal spaces. The superficial transverse perineal, 
bulbospongiosus, and ischiocavernosus muscles lie in the superficial space, while the 
deep perineal space consists of the external sphincter urethrae, the compressor urethrae 
and the deep transverse perineal muscles. The urethra passes through this urogenital 
diaphragm.                                                                                                                                                                    
                                                      
Figure 2.1 Perineum boundaries                                  Figure 2.2 Pelvic floor muscles 
Reprinted with permission from Elsevier. Copyright 2012 
                 
 Further providing support to the viscera is the endopelvic fascia that is commonly 
described as either visceral or parietal fascia. The visceral fascia connects organs to the 
pelvic wall and to each other as ligaments. It may contain neurovascular bundles 
embedded in the loose connective tissue. Parietal fascia consists mainly of dense 
connective tissue associated with the pelvic wall (tendinous arches).  
Proper pelvic function requires a balanced interaction between the muscles of the pelvic 
floor and the supporting connective tissue elements.  Maintaining an upward and forward 
position of the bladder is important for urinary continence.  In males, the prostate, 
urogenital diaphragm, perineal membrane, and bulb of the penis lie stacked like a column 
caudal to the base of the bladder.  This column and the associated ligaments act to 
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mechanically hold the bladder upward (Figure 2.3). Contraction of the levator ani moves 
the bladder superior and anterior to allow bladder filling.  It also elevates the pelvic 
diaphragm in response to an increase in abdominal pressure. The anterior movement of 
the bladder changes the angle of the bladder neck to crimp off the urethra thereby 
preventing flow. Relaxation of the levator ani allows the organs to depress and move 
posteriorly resulting in urination.  Dysfunction of any part of this unit that results in a 
change in the mobility of the pelvic organs, compromises neurovascular structures, 
and/or causes postural changes, such as may occur following surgical procedures may 
increase the chances and severity of urinary incontinence.  
 
              
Figures 2.3 Male urogenital system 
Reprinted with permission from Elsevier. Copyright 2012 
 
 
PFMT in females 
While no study has identified PF weakness as a predictor of urinary incontinence in male 
patients following prostatectomy, extensive research has been conducted on women to 
demonstrate the effect of a PFMT program in the prevention and treatment of urinary 
incontinence following childbirth and uro-gynecological procedures.  It has become 
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mainstay as a conservative management option since Arnold Kegel documented on the 
successful treatment of female stress urinary incontinence with the use of pelvic muscle 
exercises with biofeedback perineometer in 1948.80 Several Cochrane systematic reviews 
have investigated the benefits of PFMT in improving continence in women, however, the 
analyses remain inconclusive whether PFMT is better than other therapies (biofeedback, 
cones, electric stimulation, behavioral), drugs (anticholinergics), or surgeries (slings, 
colposuspension).26,81,82 A recently updated review by Dumoulin et al83 studied whether 
PFMT is an effective treatment in the management of female urinary incontinence 
compared to no treatment, placebo, sham, or control treatments.  The review provided 
support for the widespread recommendations of PFMT as a first line strategy in the 
conservative management of urinary incontinence.  Compared to the control group 
women treated with PFMT leaked less frequently and of smaller amount with the benefits 
persisting up to one year after treatment. In view of these results, Bo et al84 studied the 
role of PFMT and were able to support a biological rationale verified by ultrasonographic 
and magnetic resonance imaging.  They were able to provide two rationales: firstly that 
an intentional PF contraction clamps the urethra, thereby increasing the urethral pressure, 
and secondly that a stronger PF tone provided improved bladder neck support, thereby 
limiting its downward movement during an increase in intra-abdominal pressure (such as 
a cough or physical exertion), which in turn prevents urine leakage.  Additional studies 
have shown increased PF strength and tone in continent vs. incontinent women,85-88 and 
improved PF strength and tone in incontinent women following PFMT with resultant 




PFMT in males post-op 
As a result of the above growing body of evidence pointing to the benefits of PFMT to 
address urinary incontinence in women, PFMT has also more recently emerged as a 
conservative treatment option to address male incontinence. Individual studies have 
found modest benefits of PFMT with or without biofeedback in improving urinary 
incontinence following radical prostatectomy.  One study of 300 men compared early 
PFMT without biofeedback initiated prior to discharge to no training.97  The authors 
found that PFMT significantly reduced the time to recover continence with improvements 
noted at 1, 3 and 6 months following prostatectomy. Continence was assessed using the 
1-hour and 24-hour pad tests and defined as the use of no or one pad per day.  At 3 
months, continence was achieved in 74% of men in the treated group vs. 30% in the 
control group.  The difference declined at 6 months and by 12 months was no longer 
significant.  Other studies assessed PFMT with biofeedback compared to no training or 
usual care.47,98,99 A study by Van Kampen et al47 showed the highest success rate.   The 
PFMT program consisted of individual treatment sessions once a week while the control 
group received sham treatments.  Continence was defined as <2 grams urine loss on a 24-
hour pad test.  At 3 months after surgery 88% of the men in the PFMT group were 
continent compared to 56% in the control group.  After one year the difference reduced 
with 95% and 79% of men continent in the treatment group vs. control group 
respectively.  This finding seems to indicate the effect of PFMT decreases over time.  It 
concurs with reviews showing that the urinary symptoms following radical prostatectomy 
tended to improve over time regardless of conservative management of any type for post-
prostatectomy urinary incontinence.36,49 
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Only two studies41,100 investigated and found a physiotherapist guided PFMT to be 
beneficial in the recovery in continence following prostatectomy when compared to a 
home written/verbal PFMT program.  Other research studies have reported no significant 
difference between treatments for any outcomes at any of the evaluated times,33,35,101 
however, all groups effectively reduced their urine loss after 12 weeks of treatment.  The 
study by Overgard et al102 found no difference between groups at 3 months, but when 
PFMT continued up to one year after surgery, the improvements became apparent at the 6 
month and 12 month time with 92% continent vs. 72% in the control group by 12 months.  
The study suggested that physiotherapist guided PFMT enhanced long term adherence to 
PF exercises thereby improving continence rates over time more than information 
provided to patients for training on their own.   
The latest Cochrane Collaboration report conducted by Campbell et al48 on 37 trials 
cautioned the individual results, stating that the trials were of poor to moderate quality. 
They found that the trials were too heterogeneous in variation in the timing, type, and 
intensity of the PFMT and definition of continence, rendering conclusive and definite 
evidence difficult.  The review included trials in which men also received treatment 
before surgery and also included trials using biofeedback which were considered together 
with those without biofeedback.  A systematic review by MacDonald et al103 updates the 
findings of the Cochrane review by focusing solely on PFMT post-prostatectomy.  They 
considered biofeedback enhancement as a separate treatment method.  Their analysis 
found that 57% of subjects receiving PFMT achieved continence or were without 
continual leakage within two months compared to 37% of control subjects.  Within 3-4 
months there were no significant differences in rates of continence between the two 
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groups.  Furthermore, biofeedback enhanced PFMT was no more effective than oral or 
written PFMT instructions.  Davie et al31 in their review of 14 randomized controlled 
trials and 7 systematic reviews concurred that the current evidence demonstrates that the 
recovery time of continence can be shortened with PFMT.  Therefore, studies that have 
looked at the various treatment options in the management of post-prostatectomy urinary 
incontinence, usually strongly recommend non-invasive therapies such as PFMT (with or 
without biofeedback and/or electric stimulation) for mild to moderate incontinence in the 
early months post-operatively, as well as the addition of pharmacological therapy for 
early success.  They further suggest surgical therapies to be considered only if 
conservative therapy fails, if the incontinence is severe, or if it persists beyond 12 months 
post-operatively.29,30,63,104 
PFMT in males pre-op 
Investigators sought to explore whether pre-operative PFMT provided additional benefit 
in continence recovery in the early stages following prostatectomy.  One observational 
study compared the effects of the pre-operative physiotherapist guided PFMT versus 
verbal instructions by the surgeon when it was provided at least 4 weeks prior to the 
surgical intervention.54  The study found that the physiotherapist guided PFMT 
participants were drier at 6 weeks compared to those receiving instructions by the 
surgeon, but the effect disappeared by 3 months. Others have shown that there is no 
advantage of biofeedback over verbal instructions alone when the pre-operative PFMT 
was initiated 2-4 weeks prior to surgery.57,105,106 A RCT of 180 men conducted by 
Geraerts et al107 compared the treatment group who received PFMT weekly for 3 weeks 
pre-operatively to a control group receiving post-operative PFMT.  The PFMT consisted 
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of a 30 min therapist guided program with instructions to perform 60 contractions a day 
at home.  Continence was defined as 3 consecutive days at 0 gr of urine loss on a 24 hour 
pad test.  The results showed that both groups recovered continence to the same extent 
when assessed at the 1, 3, 6 and 12 month time points. These studies did not find that pre-
operative PFMT aided in the recovery of urinary incontinence following prostatectomy as 
none were able to show better outcomes for the patients who started PFMT pre-
operatively compared to those who started post-operatively. 
A systematic review conducted by Nahon et al53 found that 9 studies were of good to 
moderate quality, but found only 4 studies could conclusively attest to decreased time to 
continence and severity of incontinence when a PFMT program was offered pre-
operatively.  Other systematic reviews have been able to conclude that a pre-op PFMT 
program improves early continence as well as QoL, but not long term continence 
rates.108,109  A small non-randomized study compared several weeks of pre-operative 
PFMT with biofeedback to post-operative PFMT and showed faster return of continence 
in the pre-operative group at 6 weeks post-operatively.55 However, the sample size of 8 
subjects per group was too small for the author to draw conclusions with inferential 
statistics.  Parekh et al43 also found early return of continence with pre-operative PFMT, 
but the difference converged and was no longer statistically significant by 12 months.  
The same observation has been noted in other larger randomized control trials.  
Centemero et al110 investigated the effect of a PFMT initiated 30 days prior to 
prostatectomy.  Their PFMT program involved a 30-min therapist guided session twice a 
week.  Continence was defined as no leaking as reported in a bladder diary.  They found 
that pre-operative PFMT improved early continence and QoL measures at the 1 and 3 
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month follow-up times with rates of continence at 3 months of 59.3% in the treatment 
group vs. 37.3% in the control group.   Two other studies used bladder diary as the 
primary outcome for measure of continence, and QoL questionnaires as the secondary 
outcome.  Burgio et al111 found that pre-operative PFMT hastens the recovery of urinary 
control and diminishes the severity and impact of incontinence when the PFMT was 
provided in a single biofeedback session 2-4 weeks prior to surgery compared to standard 
care.  In a similar study, Tienforti et al56 arrived to the same conclusion when the pre-
operative PFMT session was provided one day prior to surgery. Both studies showed that 
the decreased incidence, duration, and severity of urinary incontinence lasted until the 6 
months follow-up.  
Wang et al58 performed a meta-analysis in an attempt to clarify the controversial issue of 
whether additional pre-operative PFMT would hasten the resolution of urinary 
incontinence after prostatectomy.  They found that only 5 studies were deemed of 
sufficient quality to qualify for inclusion in their analysis.  They found that the studies 
were able to report higher patient satisfaction and smaller impact of incontinence on QoL 
in the pre-operative groups.  However, the pooled analysis suggested no benefit on 
continence rates from the additional PFMT pre-operatively at the 1, 3, 6, and 12 month 
time points. They theorize that the lack of conclusive evidence may be due to 
heterogeneous pre-operative PFMT regimen (from 4 times to 30 minutes a day) and 
timing of initiation of the pre-operative PFMT (from one day to 4 weeks pre-surgery) in 
each study.  Furthermore, the discrepancy between the positive and negative studies has 
been suggested to lie in the choice of the primary outcome in defining continence.  The 
study by Geraert et al107 adhered to a higher standard definition of continence using pad 
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weight.  While pad tests are considered to be objective measures, patients may change 
their activity levels to prevent leakage, thus influencing the results.  Most studies that 
found an advantage to the addition of a pre-operative PFMT defined continence as no 
urinary leaking reported in a patient completed bladder diary.  Possibly incorporating an 
element of patient perception in the outcome assessment may be more relevant to the 
clinical scenario.  Another factor that may explain the discrepancy is the type of 
intervention given to the control groups.  In the studies with negative findings, control 
patients received a more intensive regimen of PFMT through written/verbal instructions 
which is different than standard or no care, and thus may also have impacted the results.  
One could speculate that even a low tech pre-operative PFMT can improve the outcomes.  
In view of these results further research is needed to elucidate optimal treatment regimen, 
duration and timing of PFMT pre-operatively, as well as definition of continence in order 
to obtain maximal urinary recovery.   
PF strength assessment 
PF muscle strength is most commonly quantified in clinical practice through manual 
muscle testing or digital palpation using the modified Oxford and PERFECT scales, 
through use of a perineometer which measures changes in pressure, or through 
electromyography (EMG) which measures the activity of the muscle.  Digital palpation 
and the use of a perineometer were first described by Kegel80 as methods to evaluate 
pelvic floor muscle function.  In women digital palpation involves placing a finger in the 
distal vagina and asking the patient to squeeze around the finger and lift inward.  
Whereas perineometer consists of a pneumatic device inserted vaginally that measures 
the pressure in mmHg performed by a pelvic floor muscle contraction.  For males the 
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assessment is done via the anal canal.  The examination per anum has been found to be a 
reproducible test of pelvic floor muscle function in men.112 The modified Oxford scale is 
a 6-point scale where 0 = no discernible PFM contraction; 1 = flicker, or pulsing under 
the examining finger, a very weak contraction; 2 = a weak contraction, an increase in 
tension in the muscle without any discernible lift or squeeze; 3 = a moderate contraction 
characterized by a degree of lifting of the posterior pelvic wall and squeezing on the base 
of the finger with in-drawing of the perineum; 4 = a good PFM contraction producing 
elevation of the posterior pelvic wall against resistance and in-drawing of the perineum; 5 
= a strong contraction of the PFM; strong resistance can be given against elevation of the 
posterior pelvic wall.60 PERFECT is an acronym with P = power (the measure of 
strength), E = endurance (timed maximum contraction held in seconds), R = repetitions, 
F = fast contractions, and finally ECT = every contraction timed.61 Both scales have been 
validated in women and found to have high reliability and reproducibility by the 
developers.61 A significant correlation was found between muscle strength measured 
using the Oxford grading scale and lift measured by finger palpation (r = 0.86; p = .03) 
and muscle strength and perineometric pressure (r = 0.79; p = .001).   Interrater reliability 
for power (r = 0.95; p < .001), endurance (r = 0.95; p < .001), repetitions (r = 0.73; p < 
.005), and number of fast contractions (r = 0.91; p < .001) were all good to excellent.  
Intrarater reliability was also excellent for power (r = 0.93; p < .001) and endurance (r = 
0.99; p < .001).  Digital palpation as a measuring tool for pelvic floor muscle strength has 
also shown high intra-observer rates of reproducibility, but low inter-examiner rates.  Bo 
et al found a Cohen s kappa value of only 0.37 even amongst highly trained 
physiotherapists.113 These findings were confirmed by several other authors.114-116  By 
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contrast sEMG does not provide a direct measure of strength, but rather measures the 
electrical activity of the muscle.59  In clinical practice surface electrodes placed over the 
perineum or vaginally or rectally are most commonly used.  Gunnarsson et al117 have 
shown that PF muscle activity can be measured reliably with sEMG, and Glazer et al118 
also found sEMG with strong clinical predictive validity in determining PF related 
disorders including incontinence.  Furthermore, studies have found moderate correlation 
(r = 0.63; p < .05) between the digital palpation and sEMG activity.119,120 Bo et al59 
concluded that the PF squeeze and lift of a contraction can be most reliably tested with 
digital palpation, while other measures of muscle function such as endurance and 
repetition are better tested with sEMG.  Both tools can be used to assess different aspects 
of PF muscle function when assessed by a single examiner.  Since a perineometer device 
was not available to the investigator, digital palpation was used to assess PF 
strength/power, while sEMG served to determine measurements of endurance (maximum 
contraction held in seconds and number of repetitions at maximum contraction).  
PF strength as an outcome measure 
Many studies that have shown an improvement rate in the recovery of urinary 
incontinence following prostatectomy have also included a measure of PF strength in 
their outcomes.  Rajkowska-Labon et al45 used surface EMG to record the activity of the 
muscle during a contraction, and found that only the response time, not the amplitude, 
showed a statistically significant difference in men who received a post-op PFMT 
program compared to men who did not, possibly indicating improved neuromuscular 
coordination.  Ribeiro et al99 showed an improvement in strength using the Oxford scale 
while Rigatti et al50 showed an increase in perineometric measures in subjects who had 
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received PFMT. The improved thickness of the PF muscles measured through magnetic 
resonance imaging by Song et al51 correlated with improved continence at 3 months.  
Finally, Ocampo-Trujillo et al52 subjected their participants to an intense pre-operative 
PFMT program consisting of supervised PFMT 3 times per day for 4 weeks. They were 
able to observe changes in the histomorphology of the PF muscles with an increase in the 
cross-sectional area of the muscle fibers, as well as higher pressures on perineometer, 
which correlated with improved continence post-operatively.  
These findings support the objectives of a PFMT program geared to improve the timing 
of a PF contraction, strength, endurance, and tone of the PF muscles, thereby increasing 
urethral pressure and limiting the downward movement of the bladder neck, thus 
preventing urinary leaking.  However, only two studies reporting on pre-operative PFMT 
included patients with RARP and all studies reporting on the use of PFMT post-
operatively were conducted following the traditional open prostatectomy.  Only one study 
compared the use of PFMT post-operatively between the open and RARP. Geraerts et 
al121 found that the patients who had undergone RARP regained continence sooner and 
scored significantly better on QoL surveys at 1 and 3 months post-operatively.  
PFMT protocols 
There are different types of PFMT. The PF muscles consist of 70% type I slow twitch 
and 30% type II fast twitch muscle fibers, with a general ratio of 2:1.79 The slow twitch 
fibers can contract for a long period of time at a low force, whereas the fast twitch 
contract for a shorter time but can generate more force than the slow twitch. The 
prominence of the slow twitch fibers in the levator ani enable it to support the pelvic 
viscera and hold the anorectal junction sphincter closed for a long period of time. 
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However, a quick contraction of the PF may be required such as with a sudden increase 
in abdominal pressure.  Therefore, it is important to integrate training to strengthen both 
types of fibers. Characteristic features of strength training include low numbers of 
repetitions with high loads which can be achieved by increasing the amount of voluntary 
effort with each contraction and by performing the exercise first with (lying) then against 
gravity (sitting, standing).  Endurance training is characterized by high number of 
repetitions or by prolonged contraction with low to moderate loads.  Currently there is no 
standard PFMT protocol.  The women s health section of the APTA provides guidelines, 
which combines the above characteristics. Furthermore, no difference was found whether 
patients received several health care professional guided sessions54,110 versus one55,56,111 
and doing the PF muscles exercises on their own.105  Therefore, this study aimed at 
providing additional insight in the benefits of a single session of pre-operative PFMT for 
those patients whose prostate CA was surgically removed through robotic-assisted 
technology.   
Quality of Life 
In general most men will experience some level of UI in the first few weeks to months 
following radical prostatectomy.  Urinary incontinence following prostatectomy has been 
reported by patients to negatively affect their quality of life (QoL).29 The incidence of UI 
post-prostatectomy varies between 0.8% and 87% in the first 3 to 6 months and between 
5% and 87% after one year.36,40,99  The study by Sanda et al122 on QoL showed that UI 
provided the highest increase level of distress post-op.  Studies that have looked at 
incidence of UI and bother on QoL long term note an impact on men s self-esteem, 
perception of own health, and impact on their existence, delaying return to work and/or 
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usual physical and social activities at one year post-op123-125 and even onwards to 2 years 
post-op.126,127 Incontinence has also been found to be associated with feelings of 
embarrassment, anxiety and fears of not being cured, and reduced confidence.128  
In studies that have looked whether post-op PFMT improved QoL scores only two 
studies53,100 reported that post-op PFMT improved function and incontinence post-op but 
no difference in QoL parameters compared to their control group was found.  However, 
the many other studies46,51,97,98,99,101,129-131 found a correlation between UI and QoL with 
noted decreased continence recovery time being associated with  lesser impact on men s 
lives in the post-op PFMT groups.  The few studies56,107,108,132 that also included pre-op 
PFMT  showed men gave a significantly better self-report on QoL up to 6 months post-
op.  One of the aims of this study was to explore whether a single PFMT session pre-op 
would aid in improving QoL measures at the early stages post-op.  
Functional Outcomes 
The impact of urinary incontinence can be assessed through health-related QoL 
(HRQOL) patient-reported outcome measures.  HRQOL addresses the entire spectrum of 
human experience, including daily necessities, interpersonal relationships, physical and 
mental health, illness, and professional and personal happiness. There are a variety of 
HRQOL available.  The questionnaires chosen for this study are the UCLA-PCI (UCLA- 
Prostate Cancer Index) and the IIQ-7 (Incontinence Impact Questionnaire) because they 
more specifically address the symptom of incontinence.  The short forms have been 
selected because they are more practical in a clinical setting and less burdensome on the 
patient.   
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The UCLA-PCI is a self-administered, multi-item disease specific instrument developed 
to capture the health concerns central to the QoL of men treated for prostate CA.133  The 
questionnaire consists of 3- to 6- point Lickert scales containing 15-disease targeted items 
that address impairment in the urinary, bowel, and sexual domains.  The psychometric 
properties have been found to be good with test-retest reliability ICC ranging from 0.66 
to 0.92 and internal consistency Cronbach  ranging from 0.65 to 0.93.  It is scored from 
0 to 100 with higher scores representing better function and less bothered by 
incontinence. 
The IIQ-7 is a condition specific instrument which was originally designed to assess 
HRQOL of middle aged and older women suffering from urinary incontinence.134 Moore 
et al135 determined that the IIQ-7 can also be used reliably with men.  The content 
validity index was 0.88 and internal consistency ranged between 0.88 and 0.92.  
Furthermore, a positive relationship was found between grams of urine loss on a 24 h- 
pad test and IIQ-7 scores (r = 0.34; p = .003 to r = 0.51; p = .001).  The domains include 
measures of physical activity, social relationships, travel, and emotional health with 
scores ranging from 0 to 100.  When the IIQ-7 scores decreased, self-reported QoL 
improved.  
CONTRIBUTION OF THE STUDY 
Urinary incontinence post-operatively is one of the main fears of men who are 
undergoing a prostatectomy due to its impact on their QoL.29  Health care providers who 
want to help their patients in dealing with the issues associated with urinary incontinence 
may be interested in simple techniques which may improve its management.  If it is 
shown that a pre-operative PFMT session aids in reducing the severity of incontinence, 
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more urologists and oncologists may want to refer their patients who will undergo a 
radical prostatectomy for PFMT.  Physicians who may want to refer their clients pre-
operatively to prevent post-operative urinary leakage, may seek providers who perform 
PFMT within their region.  Furthermore, men who choose to undergo a radical 
prostatectomy are aware of the possible post-operative complication of urinary 
incontinence and its consequences, and may request pre-operative PFMT in a proactive 
manner.   
Pelvic floor assessment is considered within the scope of practice for physical therapists 
in all State s Practice Acts.136  However, only a small portion of physical therapists 
pursue the specialization of pelvic health which includes the assessment and treatment of 
PF dysfunction.  The few that are, may not all treat men, rendering access to qualified 
therapists difficult.  However, more therapists may want to add PFMT to their services if 
its benefits are shown, thereby improving the availability of qualified providers.  
Therefore, the results of this research may further promote the benefits of a pre-operative 
PFMT session in the prevention of post prostatectomy urinary incontinence.  If it is 
indeed shown that a one-time, physical therapist guided PFMT session pre-operatively 
reduces the severity and duration of post-operative urinary incontinence following a da 
Vinci prostatectomy, more men might avoid having to manage the consequences of 
incontinence, saving them from embarrassment and cost.   
Through improved awareness, more therapists may be inclined to pursue this aspect of 
interventions, and both patients and physicians would seek providers to minimize this 
post-operative complication.  Developed awareness and improved access to the service 
would enable more men to receive this one-time pre-operative training.  This would save 
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on cost induced post-operatively to deal with the consequences of urinary incontinence, 
and improve men s post-operative quality of life more expediently. 
SUMMARY 
RARP is becoming the treatment of choice to address prostate CA in men.  However, 
despite the advanced technology, minimal invasive technique, and improved dexterity 
that allow for limited damage to the perineal structures during surgery, the post-operative 
complication of urinary incontinence remains unchanged compared to the traditional 
approaches. Researchers have been able to identify risk factors that may contribute to 
improved recovery of urinary incontinence post-operatively.  However, none of the 
factors observed in the studies included PF weakness pre-operatively.  Improved PF 
integrity and strength has been shown to improve or reduce the severity and duration of 
urinary incontinence and its impact on QoL in the early stages when a PFMT was offered 
post-operatively.  It is unclear whether offering pre-operative PFMT has additional 
benefits. No advantage was found whether the PFMT was performed over a course of 
several sessions compared to one, or whether the PFMT was supervised compared to 
done at home.  Furthermore, the results of the current literature stem primarily from 
studies of PFMT and open prostatectomy procedure, while studies of PFMT and RARP 
are scarce.     
Therefore, this study aimed at identifying the possible benefits of a one-time pre-
operative PFMT session on patients undergoing a RARP.  Whether, the PFMT aids in 
limiting the severity and duration of post-op urinary incontinence, its effect on QoL, and 
whether PF strength is a predictor. 
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           CHAPTER 3: METHODOLOGY 
INTRODUCTION 
The first portion of this study was a retrospective analysis with the primary objectives 
being that of identifying whether men who received the one session of pre-operative 
PFMT have symptoms of post-operative urinary incontinence to a lesser degree than 
those who did not, and whether certain variables such as pre-operative PF strength may 
predict better outcomes.  The second portion of the study consisted of a small prospective 
cohort study to validate the factors identified in the retrospective study.  The rationale for 
this approach is that the first portion provided a more general picture of the research 
problem, while the analysis of the second portion refined and explained the results further 
by exploring individual subjects in more depth. 
RETROSPECTIVE STUDY 
Research Method 
Phase 1 of this study employed a retrospective design to compare adult males who 
received the pre-operative PFMT and those who did not.  Age, BMI, PSA, Gleason score, 
clinical T-stage, PF strength and endurance, and a post-operative measure of continence 
recovery defined as the number of pads used were recorded.  These were compared 
between the 2 groups to answer the questions of this research: 
- Do men who receive a one-time PFMT have less incontinence following 
the robotic assisted daVinci prostatectomy than men who do not?  
- What are the differences in PF muscle strength and demographic variables 





Records were collected from the Jefferson Surgical Clinic (letter of support Appendix A) 
where two physicians routinely perform the da Vinci robotic assisted prostatectomy 
procedure, as well as from the investigator who is a physical therapist working at Back to 
Basics Family Physical Therapy, an outpatient private practice. Both clinics are located in 
Roanoke, VA.  Dr. Hayes and Dr. Daniel are board-certified urologists with 18 years and 
13 years of experience respectively, in the daVinci prostatectomy procedure.  They have 
refined their surgical technique as more evidence-based research has become available 
through the years.  The electronic charts from consecutive patients who have undergone 
the surgical procedure with and without the pre-operative PFMT session between 
1/1/2008 and 12/31/2016 were retrieved by the secretaries from both offices and 
reviewed by the investigator at the physicians  office.  To ensure the privacy and 
confidentiality of patient related data, the investigator employed a sequential numeric 
coding system that eliminates the ability to identify participants directly from the research 
records.  Access to the computer dataset was password protected and limited to the 
primary investigator.  The investigator was solely responsible for the maintenance of the 
research records which were secured in a locked cabinet.  Records from men between the 
ages of 50 and 80 years old were included.  The records were excluded if there was not 
sufficient post-operative information on the patients regarding their incontinence status, 
or if there were intra-operative complications (nerve, rectal, or ureteral injuries, or 
hemorrhage), or post-operative complications (PE, DVT, MI, wound infection).   
Based on the works of Centemero107 et al and Ocampo-Trujillo53 et al, the sample size 
calculator tool nQuery137 was used to estimate sample size.  The results indicated that a 
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minimum sample of 70 subjects per group was needed to achieve 80% statistical power.  
Data collection was performed until the minimal number of subjects required per group 
was reached. 
Procedure  
Most variables were collected from electronic chart reviews of the patients who have 
undergone the da Vinci robotic prostatectomy.  For those who had also completed a one-
time pre-operative PFMT session, data was also retrieved from the physical therapist s 
records.  
The pre-operative demographic information was recorded, including: age, BMI, ethnicity, 
level of education, symptoms if any, and stage of prostate CA (Gleason score and clinical 
T-stage), as well as PF strength (power 1-5/5) and endurance (number of repetitions and 
seconds hold) from those patients who had received the one-time pre-operative PFMT by 
the physical therapist. Intra-operative factors, such as bladder neck and neurovascular 
bundle preservation was also noted.  Post-operative information was collected at 3 points 
in time: at the post-op follow-up appointments with the surgeon at 6 weeks, 3 months, 
and one year following the prostatectomy (Figure 3.1 flow diagram).  Incidence (yes/no) 
and level of urinary incontinence (number of pads/day) was recorded. Additional 
information such as other post-operative complications, need of post-operative physical 
therapy, or whether further intervention was recommended or performed was also 






Figure 3.1: Retrospective study flow diagram  
 
Data Analysis 
Descriptive analyses include central tendency (mean, median) and variability (standard 
deviation, range, and percentage) were used.  The t-test for continuous data and Chi-
square test for nominal data was used for comparisons between the two groups.  
Furthermore, the Chi-square test was used to compare incontinence and the Mann-
Whitney test was used to compare the severity of incontinence (number of pads/day) 
between the 2 groups (Table 3.1).  Each factor was evaluated using the Chi-square 
(categorical variables), t-test (normally distributed continuous variables), or Mann-
Whitney (non-normally distributed continuous variables) test to assess its association 
with less incontinence post-operatively.  Additionally, PFM strength (1-5/5) and 
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endurance (1-10 secs and 1-10 repetitions) were analyzed within the PFMT group to 
assess whether a weaker PFM is a factor in the severity of post-op incontinence.   
The statistical analyses were conducted using the Statistical Package of Social Sciences 
software (SPSS, version 18.0). The significance level was set at the 0.05 level using a 
two-tailed test for all hypotheses.  
Table 3.1 Variables and type 
Age (years) continuous 
BMI (kg/m²) ordinal 
Ethnicity categorical (4 categories - White Black Hispanic Other) 
Level of education categorical (4 levels) Elementary High-school College           
Post-graduate 
Symptoms pre-op(Y/N) categorical (2 levels) 
PSA (ng/ml) continuous 
Gleason Score(2-10) ordinal 
Clinical T-stage(I-IV) ordinal (4 levels) 
PF muscle strength(0-5/5) categorical (3 levels)  Poor=0-1, Fair=2-3, Good= 4-5 
PF muscle endurance(1-10 
secs and 1-10 reps) 
continuous, but will be interpreted on a categorical scale 
(3levels)   Poor=1-3, Fair=4-6, Good=7- 10 
Bladder neck preserved 
(Y/N)   
categorical (2 levels) 
NVB preserved (Y/N) categorical (2 levels) 
  
Post-op UI(Y/N) categorical (2 levels) 
Severity (#of pads/day) continuous, but will be interpreted on a categorical scale 
(4 levels)   
where 0= no UI, 1-2=mild UI, 3-4=moderate UI, 
5=severe UI 







Phase 2 of this study was designed to compare two groups of subjects through a small 
prospective randomized pilot study.  The independent variable is the grouping: a sample 
of adult males who did not receive the pre-operative PFMT and a sample of adult males 
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who received the pre-operative PFMT.  The dependent variables were the measures of PF 
strength/endurance, severity of incontinence as measured by number of pads used, and 
the impact of incontinence on the patient s QoL through the condition-specific IIQ-7 and 
UCLA-PCI questionnaires.  These were compared between the 2 groups at 6 weeks and 3 
months post-operatively to answer the following research questions:  
-   Do men who present with the predictive factors identified in the 
retrospective study have less symptoms of incontinence following the 
robotic assisted daVinci prostatectomy vs. those who do not? 
- Do men who have received the one-time pre-op PFMT session present 
with improved PF strength, less incontinence, and better quality of life 
scores in the early stages following the robotic assisted daVinci 
prostatectomy compared to those who did not? 
Subjects 
For the prospective study, 20 consecutive patients who were scheduled to undergo RARP 
in 2017-2018 by Dr. Daniel from the Jefferson Surgical Clinic in Roanoke, VA were 
recruited.  Inclusion criteria were men between the ages of 50 and 80 years old.  In order 
to reduce the risks of any misunderstanding with the instructions given by the researcher, 
participants were limited to those for whom English is their primary language.  Other 
exclusion criteria included the presence of comorbidities (DM, neurological condition, 
cognitive impairment, and prior pelvic organ surgeries), sexual dysfunction, and urinary 
incontinence pre-operatively.   
The contact information of every patient who were scheduled to undergo RARP was 
provided to the secretary of the physical therapy office and the patient was contacted to 
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set-up an appointment, at which time they were also informed that they may be eligible to 
partake in a research study.  Each participant had the choice of being tested at the 
Jefferson Surgical Clinic or at Back to Basics Family Physical Therapy clinic in 
Roanoke, VA.  Potential participants were screened by the physical therapist for 
exclusion criteria before participating in the study. If at any time during the screening 
process it became apparent to the researcher that a participant did not meet the selected 
criteria, the session was abbreviated and that participant s data was not included in data 
analysis.  
All eligible patients provided a signed informed consent prior to the initiation of any data 
collection and randomi ation. At the time of enrollment, the study s purpose, protocol, 
potential risks and benefits were explained in detail.  Participants were informed that their 
participation in the study was voluntary, and that they could withdraw at any time.  Each 
participant was provided with a copy of the informed consent form (informed consent 
Appendix C).   
The randomization schedule was generated by computer using simple random 
assignment. The surgeon was blinded to intervention assignment.  From the participants 
who met the inclusion criteria and who agreed to participate by signing the informed 
consent  the same pre-operative demographics as described for the retrospective study 
were collected as well as the PF strength (power 1-5/5) and endurance (# of repetitions 
and 1-10 seconds hold) measures (data collection form prospective pre-op Appendix F) .   
Instrumentation 
PF strength and endurance was quantified using the modified Oxford and PERFECT 
scales.  PF strength was graded on a scale from 0/5 to 5/5 via the rectum with digital 
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palpation.  Digital palpation to measure PF strength has shown high intra-observer rates 
of reproducibility, but low inter-examiner rates with a Cohen s kappa value of only 
0.37.112  PF endurance was measured by sEMG via a self-adherent electrode (Easytrode 
Pregelled Electrodes) placed on the skin nearest the rectum with a dual-channel sEMG 
device (Pathway Synergy-3D, MR-20, Prometheus Group, Dover, NH).   The Pathway 
Synergy-3D is a continence evaluation and training system whereby PF function is 
measured using a pressure sensor.  The device is calibrated in accordance with 
manufacturer directions to assure measurement accuracy.  Endurance is calculated as the 
number of repetitions and seconds of a maximum voluntary contraction of the PF 
muscles before a reduction in peak force occurs on the recording.  The use of sEMG for 
the measurement of PFM activity has demonstrated good test-retest reliability (r = .86, p< 
.001) and clinical predictive validity (p< 0.05).116,117   
Procedures 
Through random assignment, the 20 participants were separated into 2 groups of 10: one 
received the pre-operative PFMT session while the other did not receive the pre-operative 
PFMT education.   An intention to treat at the completion of the study was offered if 
incontinence persisted.   Data was collected 2 weeks pre-operatively, and 6 weeks and 3 
months post-operatively (Figure 3.2 flow diagram).  The post-operative outcome 
measures included the aforementioned intra-, and post-operative variables as in the 
retrospective study, as well as PF strength and endurance, and functional assessment 





Figure 3.2: Prospective study flow diagram 
 
Testing: 
The physical examination including the assessment of the PF muscle strength and 
endurance was conducted by the primary investigator.  PF strength was assessed through 
rectal digital palpation.   The patient was in the side lying position for ease of access and 
visualization of the perineum.  The therapist inserted her index finger in the anal canal to 
the levator ani muscles and the patient was asked to contract the PF muscles by squeezing 
around the finger.  The patient was asked to pull the finger up and in, as if to stop the 
urine flow .  He was asked to squeeze the PF muscles as hard as possible for two seconds 
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while the therapist graded the PF strength.  A grade between 0 and 5 was given where 0 = 
no discernible PFM contraction; 1 = flicker, or pulsing under the examining finger, a very 
weak contraction; 2 = a weak contraction, an increase in tension in the muscle without 
any discernible lift or squeeze; 3 = a moderate contraction characterized by a degree of 
lifting of the posterior pelvic wall and squeezing on the base of the finger with in-
drawing of the perineum; 4 = a good PFM contraction producing elevation of the 
posterior pelvic wall against resistance and in-drawing of the perineum; 5 = a strong 
contraction of the PFM; strong resistance can be given against elevation of the posterior 
pelvic wall.  Observation of a cranial movement of the perineum and scrotum as well as 
the digital palpation were also used to assure the patient s ability to correctly perform a 
PFM contraction without the use of accessory muscles.  Next, the PFM endurance was 
measured with the aid of the sEMG biofeedback.   After the skin was prepped with an 
alcohol pad, the self-adherent electrode was placed on the perineal region between the 
anus and the scrotum.  For the first measure of endurance, the patient was asked to 
contract the PF muscles as hard as possible and to sustain the contraction for up to 10 
seconds.  The time when the peak is no longer sustained was recorded.  After a 60 
seconds rest period, the second measure of endurance was taken.  The patient was asked 
to repeat as many strong contractions as possible by contracting the PF muscles for 2 
seconds and resting for 4 seconds up to 10 contractions.  The number of the repetition 
when the maximum peak is no longer reached is recorded.  Thereby,  PF strength and 
endurance was quantified using the modified Oxford and PERFECT scales with one 
grade (0-5) for strength, and two grades for endurance (1-10 seconds sustained 




The intervention group received an approximately 30 minutes training session from the 
investigator 2 weeks prior to surgery.  Details were provided about the anatomy and 
physiology of the lower urinary tract and the PF muscles (hand-out Appendix E).  
Biofeedback sEMG was used for the PF exercise education portion.  Participants 
performed one set of quick contractions of 2 seconds hold with 4 seconds rest and one set 
of sustained contractions for 10 seconds with 10 seconds rest for 10 repetitions each.  
They received oral and written instructions on PFM contraction and a structured exercise 
program (hand-outs Appendix F).   Participants were asked to perform each set of the 
quick twitches and the slow twitches four times a day or for a total of 80 squeezes per day 
to be performed at home while lying, sitting, and/or standing.  They were also instructed 
on behavioral training and the use of a pelvic brace technique which involves the 
repeated use of a voluntary PF muscle contraction in response to specific situations while 
carrying out common activities of daily living, such as lifting objects, squatting, or 
coughing (HEP log Appendix G).  Participants started intervention from the day of the 
training session until the day of surgery and resumed immediately following catheter 
removal post-operatively until continence was returned. 
The non-intervention group did not receive formal education of PFMT.   These patients 
were only given oral instructions from the urologist and from the investigator on PFM 
anatomy and physiology without recommending a specific exercise regimen. 
Outcome Measures   
All patients were assessed by the physical therapist at the pre-operative session 2 weeks 
prior to surgery and at the 6 weeks and 3 months follow-up sessions.  All patients 
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completed the self-administered condition-specific questionnaires IIQ-7 (Appendix H) 
and UCLA-PCI (Appendix I).   
The primary outcome measures are degree of incontinence as defined by number of pad 
use per day (where 0 = return of continence, 1-2 = mild incontinence, 3-4 = moderate 
incontinence, and >5 = severe incontinence), IIQ-7, and UCLA-PCI scores (where 0 on 
the IIQ-7 and 100 on the UCLA-PCI indicate return of continence).  The secondary 
outcome measures are that of PF strength (where a grade of 0-1=poor, 2-3=fair, 4-5= 
good strength) and endurance (where number of repetitions and seconds held 1-3=poor, 
4-6=fair, 7-10= good endurance).  
Data Analysis 
Descriptive analyses including measures of central tendency and variability were used to 
describe all variables.  The t-test for continuous data and Chi-square test for nominal data 
was used for comparisons between the two groups for the demographics as in the 
retrospective study (see Table 3.1) with the addition of the functional questionnaires and 
measures of PF function post-operatively (see Table 3.2).  Each factor was evaluated 
using the Chi-square (categorical variables), t-test (normally distributed continuous 
variables), or Mann-Whitney (non-normally distributed continuous variables) test to 
assess its association with less incontinence post-operatively.  The variables were further 
analyzed as a function of time post-op and PFMT condition in a 3X2 mixed-model 
Analysis of Variance (ANOVA).  For the variables without a pre-op value, a 2X2 mixed-
model ANOVA was used. 
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The statistical analyses was conducted using the Statistical Package of Social Sciences 
software (IBM SPSS, version 18.0, Armonk, NY). The significance level was set at the 
0.05 level using a two-tailed test for all hypotheses.  
Table 3.2 Variables and type post-op 
PF muscle strength(0-5/5) categorical (3 levels)  Poor=0-1, Fair=2-3, Good= 4-5 
PF muscle endurance(1-10 
secs and 1-10 reps) 
continuous, but will be interpreted on a categorical 
scale (3levels)   Poor=1-3, Fair=4-6, Good=7- 10 
Post-op UI(Y/N) categorical (2 levels) 
Severity (#of pads/day) continuous, but will be interpreted on a categorical 
scale (4 levels)   
where 0= no UI, 1-2=mild UI, 3-4=moderate UI, 
5=severe UI 
 IIQ-7  (0-100) continuous, but will be interpreted on a categorical 
scale (4 levels)                                                                                                      
0=full continence, 1-33=mild UI, 34-66=moderate UI, 
67=severe UI 
UCLA-PI (0-100) continuous, but will be interpreted on a categorical 
scale (4 levels)                                                                                                        
100=full continence,99-67=mild UI, 66-34=moderate, 
33=severe UI 







                                             
    






                                             
 
                                              CHAPTER 4: RESULTS 
 
INTRODUCTION 
The primary aim of this investigation was to identify the possible benefits of a one-time 
pre-operative PFMT session on patients undergoing a RARP.  This study also attempted 
to explore whether; the PFMT aids in limiting the severity and duration of post-op 
urinary incontinence, and promoting the QoL.  In addition, this research examined 
whether the pre-operative PF strength can predict urinary incontinence after surgery. 
This chapter presents the results of the data analysis and the results corresponding to the 
specific research questions.  The research consisted of a retrospective and a prospective 
cohort study and thus this chapter is divided into two sections accordingly.  The baseline 
demographics and clinical variables are presented and the comparability of baseline 
characteristics between the men who received the PFMT and those who did not is 
examined.  The second section addresses the specific research questions for each study. 
The research questions for this study were as follows: 
1. Do men who receive a one-time pre-op PFMT have less incontinence 
following the robotic assisted daVinci prostatectomy than men who do not?  
2. What are the differences in PF muscle strength and demographic variables 
between patients with more vs. fewer incidence of urinary incontinence? 
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3. Do men who present with the predictive factors identified in the retrospective 
study have less symptoms of incontinence following the robotic assisted 
daVinci prostatectomy vs. those who do not? 
4. Do men who have received the one-time pre-op PFMT session present with 
improved PF strength, less incontinence, and better quality of life scores in the 
early stages following the robotic assisted daVinci prostatectomy compared to 
those who did not? 
For the retrospective study, the Chi-square test was used to compare whether or not 
incontinence is present and the t-test was used to compare the severity of incontinence 
between the two groups. Logistic regression analysis was used to assess the factors that 
are predictors of less incontinence post-operatively.  For the cohort study, logistic 
regression analysis was used to assess whether men who presented with the predictive 
factors have incontinence compared to those who do not.  The Mann Whitney U was used 
to compare the two groups in regards to severity of incontinence, quality of life, and PF 
strength and Friedman s ANOVA or Wilcoxon Signed Rank was used to examine 
changes over time 
RETROSPECTIVE STUDY 
Participants 
A total of 393 charts of men between the ages of 51 and 76 years old who had undergone 
RARP between 1/1/2008 and 12/31/16 were reviewed for possible study eligibility.    
Records were excluded if there was not sufficient information available, or if there were 
any intra-op or post-op complications.  Data collection was performed until the minimal 
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number of subjects (70 in each group) was reached.  One hundred and forty men with a 
mean age of 62.79 (standard deviation, 7.07) years (range, 51-76 years) satisfied the 
eligibility criteria with 70 men for inclusion in the PFMT group and 70 men in the control 
group.  Descriptive characteristics for the groups are presented in Table 4.1.  The mean 
(or median), standard deviation (or interquartile range), 95% confidence intervals for the 
mean (95% CI) and range are provided for age (K-S = .090, p = .008), weight, height (K-
S = .092, p = .005) , BMI, ethnicity, clinical T-stage, Gleason score, PSA, NVB 
preservation and year of surgery.  Comparison revealed no significant differences 
between the 2 groups for any of the variables. 
 








Question 1:  Do men who receive a one-time pre-op PFMT have less incontinence 
following the robotic assisted daVinci prostatectomy than men who do not?  
Chi Square was used to compare the presence of incontinence between the two groups at 
the 6 weeks, 3 months and 12 months post-op times (Table 4.2, Figure 4.1).  The effect 
was significant for all three time periods; 6 weeks, Fisher s Exact p = .001,  (phi) = -
0.286; 3 months, 2 (1) = 42.73, p < .001,  (phi) = -0.567; 12months, 2 (1) = 20.47, p 
< .0001,  (phi) = -0.398.  The negative sign of the Phi coefficient indicates that presence 
of PFMT is associated with absence of incontinence. 
 
Table 4.2.a Comparison of presence of incontinence at 6 weeks 
Incontinence at 6 weeks 
Incontinence 
Total  No  Yes 
PFMT         No 1 69 70 
       Yes 13 57 70 
Total 14 126 140 
 
Table 4.2.b Comparison of presence of incontinence at 3 months 
 
Incontinence at 3 months 
Incontinence 
Total  No  Yes 
PFMT       No 9 61 70 
     Yes 48 22 70 
Total 57 83 140 
 




Incontinence at 12 months 
Incontinence 
Total No  Yes 
PFMT       No 38 32 70 
     Yes 63 7 70 










The Mann-Whitney U test was used to compare the severity of incontinence through the 
number of pads used per day between the two groups. At 6 weeks, the PFMT group 
(median = 3.00) used significantly fewer pads per day than the non-PFMT group (median 
= 1.00), U = -7.65, p < .001 (see Figure 4.1). At 3 months, the PFMT group (median = 0) 
also used significantly fewer pads per day than the non-PFMT group median = 2.00), U = 












6 Weeks 3 Months 12 Months





significant difference in pad use at 12 months, U = -4.94, p < .001; the difference resulted 
from 7 PFMT patients using only 1 pad per day while the other 63 reported zero pads 
with only 38 non-PFMT patients reported zero pads while the other 32 reported a range 
from 1 to 6 pads.    
Figure 4.2 Comparison number of pads per day at the 3 time points
 
Question 2:  What are the differences in PF muscle strength and demographic variables 
between patients with more vs. fewer incidence of urinary incontinence? 
Each factor was evaluated using the Chi Square (categorical variables), t-test (normally 
distributed continuous variables), or Mann-Whitney U (continuous non- normally 
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Age: There was no significant difference between patients with and without incidence of 
urinary incontinence at 6 weeks (U = -1.353, p = .176), 3 months (U = -0.357, p = .721), 
and at 12 months (U = 1.339, p = .181. Age is not related to incidence of incontinence. 
Race: Comparisons were done between the white and non-white because there are too 
few nonwhites to analyze them in separate categories. There was no significant difference 
between patients with and without incidence of urinary incontinence at 6 weeks (Fisher s 
Exact p = .363).  Fisher s Exact test was used because at least one cell had an expected 
value less than five (5), which violates an assumption for Pearson (traditional) Chi 
Square.  At 3 months there was a significant difference between patients with and without 
incidence of urinary incontinence ( 2 (1) = 5.218, p = .022). Nonwhites (86.7%) were 
more likely to be incontinent at 3 months than Whites (59.3%). There was no significant 
difference between patients with and without incidence of urinary incontinence at 12 
months ( 2LR (1) = 0.012, p = .913).  Race was related to incontinence, but only at 3 
months. 
Weight: There was no significant difference between patients with and without incidence 
of urinary incontinence at 6 weeks (t (138) = 0.464, p = .644), 3 months (t (138) = 0.879, 
p = .381), and at 12 months (t (138) = -0.220, p = .826).  Weight was not related to 
incidence of incontinence. 
Height: There was no significant difference between patients with and without incidence 
of urinary incontinence at 6 weeks (U = -0.108, p = .914), 3 months (U = 1.391., p = 




BMI: There was no significant difference between patients with and without incidence of 
urinary incontinence at 6 weeks (U = 0.27, p = .784), 3 months (U = -0.38, p = .703), and 
at 12 months (U = -0.77p = .444).  BMI was not related to incidence of incontinence. 
PSA: There was no significant difference between patients with and without incidence of 
urinary incontinence at 6 weeks (U = -0.003, p = .997), 3 months (U = -0.405, p =. 685), 
and at 12 months (U = 0.049, p = .961).  PSA was not related to incidence of 
incontinence. 
Gleason: There was no significant difference between patients with and without 
incidence of urinary incontinence at 6 weeks (U = 0.354, p = .723), 3 months (U = -
0.409, p = .683), and at 12 months (U = -0.497, p .619).  Gleason score and incidence of 
incontinence are not related. 
Clinical Stage: Clinical stage is being treated as a categorical variable. There was no 
significant difference between patients with and without incidence of urinary 
incontinence at 6 weeks ( 2LR (2) = 0.328, p = .849), 3 months ( 2LR (2) = 2.434, p = 
.296), and at 12 months ( 2LR (2) = 0.893, p = .640).  Clinical stage and incidence of 
incontinence are not related. 
Symptoms pre-op: There was no significant difference between patients with and without 
incidence of urinary incontinence at 6 weeks ( 2LR (1) = 0.155, p = .694), 3 months ( 2LR 
(1) = 2.887, p = .089), and at 12 months ( 2LR (1) = 1.590, p = .207).  Symptoms pre-op 
and incidence of incontinence are not related. 
PFM Strength: This analysis includes only the 70 patients who received PFM Therapy. 
There was no significant difference between patients with and without incidence of 
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urinary incontinence at 6 weeks ( 2ML (2) = 0.098, p = .952), 3 months ( 2ML (2) = 2.390, 
p = .303), and at 12 months ( 2ML (2) = 0.430, p = .806).  PFM Strength and incidence of 
incontinence are not related. 
PFM Endurance: This analysis includes only the 70 patients who received PFM Therapy. 
There was no significant difference between patients with and without incidence of 
urinary incontinence at 6 weeks ( 2ML (2) = 1.950, p = .377), 3 months ( 2ML (2) = 
0.833, p = .659), and at 12 months ( 2ML (2) = 0.841, p = .657).  PFM Endurance and 
incidence of incontinence are not related. 
NVB Status: Because there were only 18 unilateral patients and only 5 no-preservation 
patients, NVB status was recoded as a dichotomous variable: Bilateral versus Other. 
There was no significant difference between patients with and without incidence of 
urinary incontinence at 6 weeks (Fisher s Exact p = .466), 3 months ( 2 (1) = 2.44, p = 
.118), and at 12 months ( 2 (1) = 0.091, p = .763).  NVB Status and incidence of 
incontinence are not related. 
PT post-operative: Post-operative physical therapy has a significant but relatively weak 
relationship with incontinence at 6 weeks, 2LR (1) = 7.995, p = .005,  = .185. Of the 
incontinent patients, 26.2% received post-op PT, while 0% of the continent patients 
received PT. At 3 months there was a moderate association between post-operative 
physical therapy and incontinence, 2LR (1) = 32.162, p < .001,  = .426.  Among the 
incontinent patients 38.6% received PT, while 1.8% of the continent patients received PT 
at 3 months.  The association between post-operative physical therapy and incontinence 
remain moderate at 12 months, 2LR (1) = 40.240, p < .001,  = .556.  Among those who 
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were incontinent, 61.5% received PT, while only 8.9% of the continent patients received 
PT at 12 months. Post-operative physical therapy and incidence of incontinence are 
related at all three time periods. 
Intervention (additional surgery post-op): At 6 weeks, there was an association between 
intervention and incidence of urinary incontinence ( 2LR (1) = 5.578, p = .018,  = .152), 
however weak. Among incontinent patients, 19.0% received further intervention, while 
0% of continent patients received an intervention at 6 weeks. At 3 months, there was a 
stronger relationship between intervention and incidence of urinary incontinence ( 2LR 
(1) = 28.449, p < .001,  = .377). Among those who were incontinent 71.1% received 
further intervention, while 0.0% of the continent patients received intervention.  At 12 
months, there was also a strong relationship between intervention and incidence of 
urinary incontinence ( 2LR (1) = 64.258, p < .001,  = .690). Among incontinent patients, 
59.0% received Intervention, while only 1.0% of continent patients received an 
intervention. Intervention post-op and incidence of incontinence are strongly related and 
the relationship gets stronger the longer the patient is post-operative.  
Of all of the demographic and pre-surgical variables, only race is related to incontinence, 
and that is only at 3 months. To see if race affects the relationship between PFMT and 
incontinence, a logistic regression was run on incontinence in which PFMT and race were 
entered as predictors. For each analysis, race was entered into the prediction first, which 
statistically controlled  for any relationship race might have with incontinence when 
testing the relationship for PFMT. At 6 weeks, PFMT was a significant predictor (p = 
.009), but race was not (p = .998). At 3 months, race was a significant predictor (p = 
.016) as expected, but its presence in the prediction equation did not eliminate the PFMT 
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as a predictor (p < .001). At 12 months, race was not a significant predictor (p = .913) 




Table 4.3.a Incontinence factors: retrospective study at 6 weeks 










No   66.0 7.5  45-73 .176 Yes   63.5 7.3  44-76 
Race 
 (% white) 
No 100.0      .067 Yes 88.1      
Weight 
(lbs) 
No  195.2  23.1 181.9-208.6 155-228 .644 Yes  198.9  29.1 193.8-204.1 150-306 
Height 
(feet) 
No   5.8 0.25  5.6-6.2 .914 Yes   5.9 0.33  5.1-6.4 
BMI No  27.7  3.24 25.9-29.6 21.6-33.5 .575 Yes  28.3  3.84 27.6-29.0 20.5-40.1 
PSA No   5.92 2.33  3.28-8.30 .997 Yes   5.60 3.24  1.55-28.14 
Gleason (% 
Score = 6) 
No 64.3      
.165 Yes 53.2      
Clinical 
Stage (% 
Stage = I) 
No 50.0      
.849 Yes 43.7      
Symptoms 
(% none) 
No 78.6      




No 30.8      




No 7.7      




No 92.9      





No 0.0      




No 0.0      




Table 4.3.b Incontinence factors: retrospective study at 3 months 










No   64.0 10.0  44-76 .721 Yes   62.0 8.0  44-76 
Race 
(% white) 
No 96.5      .015 Yes 84.3      
Weight  
(lbs) 
No  196.0  24.4 189.5-202.5 150-250 .381 Yes  200.3  30.9 193.6-207.1 150-306 
Height 
(feet) 
No   5.8 0.33  5.4-6.2 .164 Yes   5.9 0.42  5.1-6.4 
BMI No  28.2  3.19 27.3-29.0 21.6-37.0 .796 Yes  28.3  4.15 27.4-29.2 20.5-40.1 
PSA No   5.92 3.12  1.72-28.14 .685 Yes   5.60 2.90  1.55-15.10 
Gleason (% 
Score=6) 
No 54.4      




No 50.9      
.396 Yes 39.8      
Symptoms 
(%  none) 
No 66.7      
.089 Yes 79.5      
PFM  
Strength 
 (% Good) 
No 29.2      




No 14.6      




No 89.5      





No 1.8      




No 0.0      




Table 4.3.c Incontinence factors: retrospective study at 12 months 










No   64.0 8.5  44-76 .181 Yes   65.0 7.0  49-76 
Race 
(% white) 
No 89.1      .913 Yes 89.7      
Weight 
(lbs) 
No  198.9  29.9 192.9-204.8 150-306 .826 Yes  197.7  24.6 189.7-205.7 150-240 
Height 
(feet) 
No   5.8 0.33  5.4-6.4 .137 Yes   5.9 0.42  5.1-6.4 
BMI 
No  28.4  3.88 27.7-29.2 21.6-38.7 
.452 Yes  27.9  3.54 26.7-29.0 20.5-40.1 
PSA No   5.75 2.95  1.55-28.14 .961 Yes   5.90 3.90  3.60-15.10 
Gleason (% 
Score = 6) 
No 53.5      
.649 Yes 56.4      
Clinical 
Stage (% 
Stage = I) 
No 46.5      
.640 Yes 38.5      
Symptoms 
(% none) 
No 77.2      




No 31.7      




No 12.7      




No 84.2      





No 8.9      
.001 Yes 61.5      
Intervention 
(% Yes) 
No 1.0      






A total of 49 men between the ages of 53 and 72 years old who underwent RARP 
between November 2017 and November 2018 were screened for possible study 
eligibility.  Men were excluded if their surgery was scheduled less than 2 weeks from the 
interview, if there was a language barrier, presence of co-morbidities (DM, neurological 
conditions, cognitive impairment, or prior pelvic surgeries), sexual dysfunction, or 
urinary leaking pre-op, or if there were post-op complications.  Screening was performed 
until 20 men who met the inclusion criteria accepted to participate in the study.  Of the 29 
men who did not participate, 6 declined, 14 had co-morbidities, 1 had urinary leaking 
pre-op, 7 had their surgery scheduled within a week of the screening date, and 1 had post-
op complications.  The 20 participants chose to be seen at the physical therapy clinic.  
They signed the informed consent form and 10 each were randomized in either the PFMT 
group or the control group through computer generated simple randomization.  Men who 
were assigned an odd number were placed in the control group, while those who received 
an even number were placed in the intervention group.  Data collection was performed 2 
weeks prior to surgery and at the 6 weeks and 3 months post-op times. Demographic and 
clinical data for the groups are summarized and presented in Table 4.4.  The mean (or 
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median), standard deviation (or interquartile range), 95% confidence intervals for the 
mean (95% CI) and range are provided for age, weight, height, BMI, ethnicity, clinical T-
stage, Gleason score, PSA, NVB preservation, PFM strength and endurance, and level of 
education.  All continuous variables were tested for normality using the Kolmogorov-
Smirnov test.  Because of small sample sizes all group comparisons were accomplished 
with Mann-Whitney U or Chi Square. Changes over time (repeated measures) were 
assessed via Friedman s ANOVA or Wilcoxon Signed Rank.  There are no differences 
between the groups. 




Question 3:  Do men who present with the predictive factors identified in the 
retrospective study have less symptoms of incontinence following the robotic assisted 
daVinci prostatectomy vs. those who do not? 
As is noted in Table 4.4, there was no demographic differences between the PFMT and 
control groups. Race was the only demographic variable related to incontinence in the 
retrospective study and, in this study small numbers required it be reduced to categories 
of white and non-white. 
Chi Square with Fisher s Exact test was used to assess the correlation between race and 
incontinence.  Correlation was not found at 6 weeks (p = .495; with 10 whites and 2 non-
whites incontinent, 8 whites and 0 non-whites continent), or at 3 months (p = .479; with 9 
whites and 2 non-whites incontinent, 9 whites and 0 non-whites continent).    
Question 4:  Do men who have received the one-time pre-op PFMT session present with 
improved PF strength, less incontinence, and better quality of life scores in the early 




Variables were analyzed as a function of time and PFMT condition in a 3 (Time: pre-op, 
6 weeks, 3 months) X 2 (Condition: PFMT vs. Control) mixed-model Analysis of 
Variance; Time is a repeated-measures variable and Condition is a between-subjects 
variable. For variables without a pre-op value, a 2 (Time) X 2 (Condition) mixed-model 
ANOVA was used. 
PFM Strength: There is a significant main effect for time, F(2,36) = 4.415, p = .038, 
partial 2 = .197. PFM Strength increased over time. Neither the main effect for 
Condition, F(1, 18) = 0.917, p = .351, partial 2 = .048, nor the Time X Condition 
interaction, F(2, 36) = 1.358, p = .266, partial 2 = .070, were significant. The PFM 
strength seemed to increase more in the PFMT group comparing to the control condition 
(Figure 4.3) but the difference was not statistically significant. 
 





PFM Endurance: The results for PFM Endurance display a pattern similar to that for PFM 
Strength. There is a significant main effect for Time, F(2,36) = 20.027, p < .001, partial 
2 = .527. PFM Endurance increased over time, and the effect size is quite large. Neither 
the main effect for Condition, F(1, 18) = 0.100, p = .755, partial 2 = .006, nor the Time 
X Condition interaction, F(2, 36) = 2.514, p = .095, partial 2 = .123, were significant.  
The PFM endurance seemed to increase more in the PFMT group comparing to the 
control condition (Figure 4.4) but the difference was not statistically significant.  
 
Figure 4.4 PFM Endurance as a Function of Condition and Time 
 
Urinary Incontinence: Changes in the rate of urinary incontinence between conditions 
were assessed via Fisher s Exact Chi Square separately for occurrences at 6 weeks and at 
3 months. As is evident in Table 4.8 below, incontinence was significantly more likely in 









Table 4.5 Urinary Incontinence as a Function of Condition and Time 
  Condition  
Time Post-op Incontinence Control PFMT  
6 Weeks 
N   0 8 
p < .001 
Y 10 2 
3 Months 
N   1 8 
p < .006 
Y   9 2 
 
Pads per Day: Wilcoxon Signed Rank nonparametric test was used to compare number of 
pads at 6 weeks versus 3 months; there is a significant difference, W = -2.81, p = .005, 6-
Week Median = 1, Interquartile range = 3; 3-Month Median = 0, Interquartile range = 2. 
Fewer pads per day were used at 3 months than at 6 weeks. Mann-Whitney U test was 
intended to be used to test for differences between conditions (PFMT versus Control). 
For 6 weeks, it was not possible to conduct an analysis because there was too little 
variability in the PFMT group. As is evident in Figure 4.8 below, only two participants 










Figure 4.5 Pads per Day as a Function of Condition at 6 Weeks 
 
 
The same issue with variability occurred at 3 months post-operative. Only one participant 
(#12) in the PFMT conditions was still using a pad at 3 months (Figure 4.6). There was a 
distribution of pads used in the control condition, with a median value of 1.5 pads per 
day. Thus, despite the lack of a statistical test, it is obvious that fewer pads per day were 











Figure 4.6 Pads per Day as a Function of Condition at 3 Months 
 
 
IIQ7: IIQ7 scores at 6 Weeks and at 3 Months are normally distributed, so a 2 (Time) X 2 
(Condition) ANOVA was used to examine mean differences. Both main effects were 
significant, but not the interaction. IIQ7 for the PFMT group (M = 20.45, SE = 5.74) was 
significantly lower, F (1,18)  = 8.77, p = .008, partial 2 = .328, than the mean for the 
control group (M = 45.50, SE = 5.74). Also, IIQ7 at 6 weeks (M = 40.70, SE = 4.74) was 
significantly higher, F (1, 18) = 15.98, p = .001, partial 2 = .470, than the mean IIQ7 at 3 
months (M = 24.25, SE = 4.36). As is evident in Figure 4.7, the advantage for the PFMT 
was consistent at both times; the interaction was not significant, F(1, 18) = 0.83, p = .374, 
partial 2 = .044. It is worth noting that the mean score for the control group at 3 months 






Figure 4.7 IIQ-7 Scores as a Function of Condition and Time 
 
 
UCLA-PCI Function: Scores on the UCLA Function measure are normally distributed, so 
a 2 (Time) X 2 (Condition) ANOVA was used to examine mean differences. Both main 
effects were significant, but the interaction was not, F (1,18) = 0.54, p = .470, partial 2 = 
.029.  Those who received PFMT (M = 69.42, SE = 5.60) scored significantly higher, F 
(1,18) = 21.82, p < .001, partial 2 = .548, than those in the control group (M =  32.46, SE 
= 5.60).  Function score was higher at 3 months (M = 56.61, SE = 4.32) than at 6 weeks 
(M = 42.28, SE = 4.33), F (1,18) = 12.01, p = .003, partial 2 = .400. The pattern is 








Figure 4.8 UCLA-PCI Function Scores as a Function of Condition and Time 
 
 
UCLA-PCI Bother: The UCLA-PCI Bother scores were not normally distributed, K-S6 
weeks = .258, p = .001, K-S3 months = .216, p = .016, so Mann-Whitney U tests were 
performed to test for differences over time as well as differences between groups.  In 
Figure 4.9 it is apparent that the PFMT group scored significantly higher at 6 weeks (U = 
3.10, p = .002), and at 3 months (U = 2.84, p = .005), than the control group. Both groups 
improved over time, however the change did not yield statistical significance, PFMT W = 

























                                               CHAPTER 5: DISCUSSION 
 
INTRODUCTION 
The primary purpose of this research was to explore the benefit of receiving a one-time 
pre-operative PFMT in men following a da Vinci robotic-assisted radical prostatectomy 
(RARP).  Despite advancing technology and the use of techniques geared to preserve or 
reconstruct the surrounding peritoneal fascia, bladder neck, and neurovascular bundle 
(NVB) the most common side effects remain impotence and urinary incontinence.  As 
many as 87% of men may experience incontinence immediately following 
prostatectomy1,2,18 thus impacting one s quality of life.  
 Four specific questions were developed in order to test the relationship between a one- 
time pre-op PMFT session and urinary incontinence post-op. The first two questions, 
which were explored through a retrospective study, were on whether the individuals who 
received the pre-op PFMT had less incontinence than those who did not, as well as 
identifying factors that are associated with less incidence of urinary incontinence post-
operatively.  The last two questions, through a prospective cohort study, were on whether 
the men who presented with the predictive factors identified in the retrospective study 
had less incontinence than those who did not, and whether men who have received the 
one-time pre-op PFMT session present with improved PF strength, less incontinence, and 
better quality of life scores following the robotic assisted daVinci prostatectomy 
compared to those who did not. 
This chapter discusses the findings and compares the results to previous work in the 
literature, and the contribution of this study to the clinical management of men who will 
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be undergoing RARP.  The limitations and recommendations for future research and a 
summary of conclusions were also provided. 
INCIDENCE OF UI POST-OP 
Research questions 1 and 4 addressed whether men who received the pre-op PFMT have 
less incontinence following the RARP than the men who did not.  There was a significant 
difference between the 2 groups at the 3 points in time such that the men who received 
the pre-op PFMT were more likely to be continent and also to a lesser degree even if they 
were still incontinent than the men who did not receive the pre-op PFMT, with the 
strongest effect at 6 weeks in both the retrospective and prospective studies.   
The results agree with previous studies43,55,56,110,111 where it was also found that decreased 
time to continence and severity of incontinence was present when a PMFT program was 
offered pre-operatively.  However, these studies provided one or more pre-op PFMT 
sessions, as well as post-op PFMT.  The current study provided only one pre-op session 
and no post-op PFMT with the noted improvements.   Therefore it results in potential cost 
saving for the patients and the healthcare system by reducing the total number of visits 
required.  It was not the intent of this study to provide evidence on the ultimate number of 
visits in order to maximize the effect. The ideal number of visits that can maximize the 
benefits of PFMT still warrant further investigation.   
The result is consistent with studies in which the advantage provided by a PMFT program 
decreases over time. The results of this study generally show a stronger effect at 6 weeks 
post-op.  Parekh et al43 also found a PFMT advantage for early return of continence at 6 
weeks and up to 3 months, but that advantage was no longer significant at 12 months.  
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Centemero et al110 investigated the effect of a PFMT initiated 30 days prior to 
prostatectomy.  They found that pre-operative PFMT improved early with the rates of 
continence of 59.3% at 3 months in the treatment group comparing to only 37.3% in the 
control group.   In the current study, the rate of continence at the same 3 months post-op 
timeframe were a little higher in the PFMT group (68.6%) but lower in the control group 
(12.9%). Two other studies54,55 have shown the most advantages of pre-op PFMT at the 
early stages of 6 weeks post-op.  Patel et al54 conducted a retrospective study on the 
effect of 4 weeks of pre-op PFMT and also post-op PFMT and concluded the most 
significant difference occurs at 6 weeks.   A study by Sueppel et al, though with only 8 
men, also demonstrates the strongest results at 6 weeks post-op with only one session of 
pre-op PFMT.55 
From the data collected for the retrospective study, the single PFMT session was 
provided between 3 weeks to one day pre-op while the pre-op PFMT session was 
generally provided 2 weeks pre-op for the prospective study.  Studies have shown 
benefits to pre-op PFMT sessions whether provided as several weekly sessions or as ours 
as a single session and up to one month pre-op.   Burgio et al111 provided a single 
biofeedback PFMT session 2-4 weeks prior to surgery and in a similar study, Tienforti et 
al56 provided the PFMT session only one day prior to surgery. Both studies also provided 
post-op PFMT and found that their pre-operative PFMT hasten the recovery of urinary 
control, with decreased incidence, duration, and severity of urinary incontinence lasting 
until the 6 months follow-up.  
Conversely, the study by Geraerts et al106 shows no benefit from pre-op PFMT compared 
to post-op PFMT sessions.  They found that both groups recovered continence to the 
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same extent and that there was no difference in the time to continence when assessed at 
the 1, 3, 6 and 12 month time points.  In this retrospective investigation, among those 
who received pre-op PFMT only 3 men required post-op PFMT and 2 required further 
surgical interventions vs. 30 men in the control group required post-op PFMT and 23 
required surgery.  Only one in ten men in the control group of the prospective study 
required post-op PT once the study was completed.  With the similar results as having 
several post-op sessions, one could argue that one pre-op session has more value, is more 
cost effective and less bothersome to men undergoing RARP comparing to post-op 
training.  
While studies have found no benefit of biofeedback vs. verbal instructions58,104 or the use 
of E-stim vs. PMFT alone105, our pre-op PFMT consisted of verbal instructions in 
combination with biofeedback.  This was chosen in order to assure that a correct PF 
contraction was performed in isolation and also as a means to measure PF endurance.  
The men who did not receive the pre-op PFMT session only received verbal instructions 
from the surgeon or they found information on the internet without specific protocol and 
guided instruction. One observational study55 compared the effects of the pre-operative 
physiotherapist guided PFMT versus verbal instructions by the surgeon provided 4 or 
more weeks prior to the surgical intervention. The study found that at 6 weeks the 
physiotherapist guided PFMT participants were drier compared to those receiving 
instructions by the surgeon, but the effect disappeared by 3 months. In this study, 
additional written instructions regarding exercise regimen and behavioral strategies to 
prevent leaking during functional activities were also provided by the therapist.  This 
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additional education/information may account for the improvements noted compared to 
PF exercises alone when provided through written or verbal instructions.   
In conclusion, the response to the question whether men who received the pre-op PFMT 
have less incontinence following RARP than the men who did not is a resounding yes.  
The key difference between this study and other studies is that this study showed the 
benefit of one single session pre-op in reducing the severity of incontinence post-op at the 
very early stages at 6 weeks post-op.   
ASSOCIATED FACTORS 
Research questions 2 and 3 addressed whether any factors, such as PF muscle strength 
and demographic variables, are associated with less incidence of urinary incontinence.  
The factors included age, race, height, weight, BMI, PSA, Gleason score, clinical T-
stage, symptoms, PF strength, PF endurance, and NVB status. 
In our study none of the pre-op demographics were shown to be related to incontinence 
post-op including PF strength and endurance.  Of all the demographics and pre- and peri-
surgical variables, only race was related to incontinence in the retrospective study and 
that only at the 3 months mark. No other studies have looked at race as a predictor of UI 
post prostatectomy. However, further analysis revealed that its presence did not affect the 
relationship between PFMT and incontinence.   
Two small scale studies7,72 found that lower BMI correlated with a faster return of 
continence at 12 months post-op. However, other studies support our findings.  The study 
by Novara et al74 found that no variables related to prostate CA correlated with UI post-
op.  A large study by Nilsson et al73 did not find that BMI had an effect on the prevalence 
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of UI at a 2 year follow-up.  Lavigueur-Blouin et al22 also found that BMI and PSA were 
not statistically significant predictors of very early continence.   
All previous studies5,7,20-23,71,72,74,76 that have looked at age as a predictor of risk of UI 
post-prostatectomy have found that younger age (<70 years old) correlates with faster 
return of continence.  Only 19 patients out of 140 men in the retrospective study were 
over the age of 70 years old with a median of 62.5 years old for the control group and 65 
years old for the PFMT group.  Only 2 out of 20 men in the prospective study were over 
the age of 70 years old with a median of 62 years old for both the control and the PFMT 
groups.  This renders our population in the younger age range and thus may be attributed 
to the lack of relationship found.  
Studies generally agree that a nerve sparing technique is superior to a non-sparing 
technique and is associated with recovery of continence at one year post-op5,7,20 and as 
early as 3 months post-op.9,21,75,77,78  The surgeons participating in this study commonly 
use a nerve sparing technique in which 84% of men received the bilateral nerve sparing 
and 13% the unilateral nerve sparing technique in the retrospective study.  Five out of 20 
men in the prospective study received the unilateral nerve sparing technique.  The study 
by Kaye et al7 reported similar recovery with either technique and thus this may also be 
the reason for lack of relationship in our research as only 5 men underwent a non-sparing 
procedure in the retrospective study.   
A few studies76,77 have also reported on improved continence within 3 months post-op 
with a lower T-stage and Gleason score.  A higher stage or Gleason score of 7 or more 
indicates a more aggressive CA.  Ninety-four percent in the retrospective study and 100% 
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in the prospective study of our population was categorized in the grades I or II T-stages 
and at a median of 6 on the Gleason score.  Most likely early diagnostic screening 
accounts for the early detection of prostate CA before the CA has had a chance to grow 
outside the prostate and become more aggressive.  Surgical procedures therefore do not 
need to be as invasive and do not cause as much damage to the surrounding tissues when 
the CA is better contained and thus possibly accounts for the lack of correlation noted in 
our research. 
In conclusion, this study did not identify any factors, including PF strength and 
demographic variables that were associated with incidence of urinary incontinence post-
op.  In such, this study shows that regardless of pre-op variables, it was the PFMT session 
pre-op that aided in reducing the severity of incontinence post-op. 
PF STRENGTH/ENDURANCE 
The relationship between PF strength/endurance and incontinence is further explored in 
questions 3 and 4.   
This study used rectal digital palpation and the Oxford scale to grade PF strength and did 
not show that PF strength pre-op was a predictor of continence post-op.  Even men with 
good strength have some chance of developing urinary incontinence.  However, the 
prospective study shows that there is an inverse relationship between urinary 
incontinence and PF strength/endurance in that men with good PF strength/endurance are 
less likely to experience urinary incontinence and those with poor PF strength/endurance 
are almost certain to have urinary incontinence at both 6 weeks and 3 months post-op.  
This relationship between PF strength/endurance and urinary incontinence gets stronger 
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over time.  There are a few studies correlate PF muscle weakness to incidence of urinary 
incontinence following radical prostatectomy, but only one other also notes the 
relationship getting stronger over time.  The pilot study by Rigatti et al51 used 
perineometric measures pre-op and post-op to assess PF tone and found a significant 
difference between pre-op pressures in continent vs. incontinent men post-op at 1 and at 3 
months when all men received PFMT pre-op and post-op.  
Song et al52 used MRI as a means to measure the thickness of the PF muscles and 
established that continence was related with increased thickness at 3 and 6 months post-
op, but PFMT was not provided in their study.  The study by Ocampo-Trujillo et al53 
shows histologic PF muscle changes through an increase in cross-sectional area of the 
muscle fibers of the external urethral sphincter which correlated with higher pressures of 
PF contraction and improved continence.  However, the pre-op PFMT consisted of a 30 
days intense training prior to surgery. In this study the one pre-op session occurred less 
than 3 weeks prior to surgery and thus morphological changes most likely did not occur 
yet. 
The study by Ribiero et al99 also used the Oxford scale to quantify PF strength but 
examined the effects of early post-op PFMT.  They found that improved PF strength 
hasten the recovery of continence in the PFMT group up to 12 months post-op.   
The prospective study we conducted shows that PF strength and endurance improve 
significantly over time in both groups but more rapidly in the PFMT group, though not 
statistically significant.  Incontinence, however, is significantly more likely in the control 
group at 6 weeks and 3 months, with noted fewer pads/day used in the PFMT group. 
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The lack of significance in this prospective study in regards to improvements in PF 
strength/endurance may be due to the small sample size, but also because of subjects in 
our control group were doing some type of Kegel exercises either found on the internet or 
as recommended by the surgeon.  The improvements seen in the severity of incontinence 
post-op in the PFMT group may therefore align with the rationale originally suggested by 
B∅ et al84 that an intentional PF contraction clamps the urethra, thereby increasing the 
urethral pressure, and that a stronger PF tone provided improved bladder neck support, 
thereby limiting its downward movement during an increase in intra-abdominal pressure 
which in turn prevents urine leakage.  The men in the PFMT group were taught how to 
perform a correct and isolated PF contraction with additional instructions in what is 
commonly called a Knack maneuver.  This consists of a pelvic bracing technique to be 
used during such activities that may be causing an increase in intra-abdominal pressure 
that may result in a leak, such as while coughing/sneezing, lifting or during changes of 
position.  The study by Rajkowska-Labon et al46 used sEMG to record PF muscle activity 
and assess post-op improvements in continence through PFMT and found a statistically 
significant difference in response time, indicating improved neuromuscular coordination.  
This could further explain our findings of improved continence in the intervention group.  
QUALITY OF LIFE 
The effect of pre-op PFMT on the QoL scores was explored in research question 4.  The 
IIQ-7 and UCLA-PCI urinary domains were used to assess the impact of incontinence on 
quality of life.  
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This prospective study where men received only one pre-op PFMT session found the 
functional impact of UI to be getting smaller over time in both groups, but with a 
significant lesser impact on QoL in the PFMT group.  Furthermore, the impact at 3 
months in the control group was still higher than the impact to the PFMT group at 6 
weeks.  No other study has previously noted this finding.  The measure of the impact of 
UI on QoL relies on self-reporting measures.  Possibly the men in this study were aware 
that the measure of the severity of UI was the primary purpose of this investigation and 
wanted to show good results.  A two year follow-up study by Sacco et al18 showed that 
QoL is not impacted in men using <1pad/day, but is impacted in men using > 2 pads/day.  
In our study, men who received the PFMT session all used 0 or 1 pad/day by 6 weeks and 
thus may attest for the significantly improved QoL scores at this point in time.  
Studies further show that self-esteem and health locus of control influence QoL.138 A 
recent large-sized prospective trial found that preparedness before surgery for urinary 
problems decreases the impact of UI up to one year post-op.139 The pre-op PFMT and 
education in behavioral strategies provided in this study possibly result in reassurance for 
the patients and improve their confidence that urine can be controlled or stopped in 
situations where leaking could occur.  Therefore helping to overcome the physical, 
psychosocial, and emotional problems derived from the loss of bladder control in the first 
few months following surgery. 
In conclusion, the functional impact of incontinence gets smaller over time in both 
groups, but with a significant lesser impact on QoL in the PFMT group.  The impact at 3 




IMPLICATIONS AND RECOMMENDATIONS 
PF Strength and Endurance 
The primary finding of this investigation is the strong association between PFMT pre-op 
and the reduced incidence of UI post-op at all points in time, with the strongest effect 
being at 6 weeks post-op with only one pre-op PFMT session.  Furthermore, PF 
strength/endurance improved more rapidly in the PFMT group with the resulting impact 
of UI on QoL less bothersome in the PFMT group.   This effect was also strongest at the 
6 weeks post-op point.  Further larger studies are needed to corroborate the findings of  
this study and to determine whether 1 session only pre-op is beneficial.  However, this 
preliminary research appears to support the benefits of a pre-op PFMT program. Based 
on these findings, prophylactic PFMT could be recommended for patients undergoing 
RARP and could be part of the guidelines for management of UI as a routine pre-op 
preparation prior to RARP in urology practice. 
Even though the study failed to identify PF strength and endurance as predictors of UI 
post-op, the relationship between PF strength/endurance and UI post-op was shown to be 
getting stronger over time. The one-time session of PFMT was provided anywhere 
between 1 day to 3 weeks pre-op.  Possibly initiating PFMT at least four weeks prior to 
surgery would allow for muscle bulk/tone51,52 and improved strength50,99 to occur prior to 
surgery, thereby improving urinary control sooner post-op.  Recommendations in 
behavioral strategies should be provided as well, including the use of a pelvic bracing 
technique during functional activities that may cause UI post-op.  This would allow for 
the practice of this essential skill pre-op when the perineum is still intact.  Patients would 
be able to stop urine flow in situations of an increase in intra-abdominal pressures or with 
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urgency.  Giving patients reassurance and improved confidence that urine can be 
controlled would help overcome the physical, psychosocial, and emotional problems 
derived from loss of bladder control.   
PFMT programs 
In most clinical practice a post-op PFMT program would typically be initiated once the 
severity of UI has been established on follow-up with the surgeon, generally 4-6 weeks 
post-op.  This study shows improvements of UI and less bother from UI by 6 weeks.  Of 
all the patients who received the pre-op PFMT none required post-op PFMT in the 
prospective study and only 3 out of 70 men in the retrospective study.  Most pre-op 
PFMT programs including this one consist of 1 to 4 sessions.  By contrast there is high 
variability in terms of duration of programs (3 to 12 months) and number of visits 
(ranging between 9 to 48 sessions) in studies that offered post-op PFMT28,39.  Therefore, 
initiating PT interventions pre-op translates to a potential cost saving for patients and the 
healthcare system by reducing the total number of visits required for successful motor 
learning to occur.   
Future research 
Both the retrospective and prospective studies were conducted based on patients coming 
from one surgical clinic.  The data was collected by one physical therapist and therefore 
the results are biased and not generalizable to the larger population and geography.  A 
study which would include several clinical sites and in various States, provided that there 
is standardization between surgeons and therapists, would allow for better 
generalizability.   
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Furthermore, this was a pilot study and the sample only included 20 men.  A similar 
study with a larger sample size needs to be conducted to verify the results found in this 
pilot study.  A larger sample size would thereby allow for greater statistical power. 
In this study, the pre-op session was performed less than 3 weeks prior to surgery and did 
not identify PF strength pre-op as a predictor of UI post-op.  However, our results did 
show a relationship between PF strength and UI which was getting stronger over time. 
Men who had good  PF strength were less likely to experience UI.  Therefore, a study 
where the pre-op session is performed a month prior to surgery may allow sufficient time 
for improved PF bulk to occur and possibly then render PF strength to have an effect on 
UI post-op.   
Of all potential associated factors analyzed only race was found to be significant.  Non-
whites were experiencing more UI than whites, however only at the 3 months post-op 
time point in the retrospective study.  It would be interesting to study a larger sample 
with non-whites to see whether this was an aberrant finding or not. 
Finally, the portion of our study that investigated the impact of UI on QoL noted 
significantly less impact in the PFMT group at 6 weeks. QoL scores were even better 
than the control group at 3 months post-op.  A study that would look at QoL at 6 weeks 
post-op comparing men who received a pre-op PFMT to men who received immediate 
post-op PFMT would further corroborate the importance and advantages of a pre-op 





LIMITATIONS AND DELIMITATIONS 
The primary limitations of this research pertains to its generalizability. The small sample 
size of the pilot study as discussed previously is a limitation.  Also, the research was 
limited to one clinic and surgical site, thereby limiting the selection of men who 
underwent RARP to local and primarily white men. In 2018, the census bureau140 notes a 
population consisting of 60.7% Whites, 13.4% Blacks, 5.8% Asians, and 18.1% 
Hispanics.  The retrospective study consisted of 89.3% Whites, and only 8.6% Blacks 
and 2% Hispanics, and the prospective study has 90% Whites and 5% each of Blacks and 
Asians, and thus not representative of the general population.  Furthermore, delimitations 
in the prospective study are associated with the inclusion criteria which influence the 
generalizability of the findings further.  The inclusion criteria were chosen to assure a 
more homogenous group for comparison purposes.  However, in this age group it is not 
uncommon to have co-morbidities and thus this sample is not representative of the 
general population and findings cannot be generalized. 
Another limitation in the retrospective study stems from the nature of such analysis.  This 
type of research does not allow for experimental control over the original data collection 
process.  Demographics and clinical data was extrapolated from the medical records of 
consecutive men who received RARP between the years of 2008 and 2016.  Because of 
missing data, in order to reach the required sample size, the year of surgery was extended 
to prior to this therapist s collaboration with the surgeons and thus original data was also 
gathered by two other therapists.  Standardization of protocol between the therapists 
could not be established.  However, these other therapists are known to this investigator 
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and have completed similar training in the assessment of male PF strength.  Therefore, 
data was deemed to be included and supports the validity of the findings.   
In the prospective study all the measurements were performed by the same examiner and 
therefore the examiner was not blinded to group assignment.  Also all RARP were 
performed by the same surgeon.  This represents examiner and surgeon bias, however it 
improved the reliability of the measurements and procedure.  
The benefits and results of a PFMT to improve PF strength and improve the symptoms of 
urinary incontinence are contingent to patient compliance and motivation.  The measure 
of the severity of UI relied on the number of pads used per day, which represents a semi-
quantitative and subjective measure. It also relied on functional questionnaires which are 
self-reporting measures.  Men who participated in the prospective study were aware that 
the measure of severity of UI was the primary purpose of the research and possibly 
wanted to show good results and thus may affect our findings. 
Due to the variability of the definition of continence and measure used in other studies, as 
well as the lack of a standard protocol for the PFMT session between studies, the results 
of our study cannot accurately be compared to previous studies. 
Finally, the lack of normality and homogeneity of group variances and linearity among 
the predictors, as well as the small sample size of the prospective study which required 






The primary aim of this research was to explore the relationship between receiving a one-
time pre-operative PFMT and the occurrence of post-operative urinary incontinence and 
the impact on quality of life in men following a da Vinci robotic-assisted radical 
prostatectomy (RARP).  Four questions were developed in order to examine this 
relationship. The first two questions were explored through a retrospective study and 
included whether the men who received the pre-op PFMT had less incontinence than 
those who did not, as well as the factors that may be associated with less incidence of 
urinary incontinence post-op.  The next two questions were explored through a cohort 
prospective study and included whether the men who presented with the predictive 
factors identified in the retrospective study had less incontinence than those who did not, 
and whether men who have received the one-time pre-op PFMT session present with 
improved PF strength, less incontinence, and better quality of life scores immediately 
following the robotic assisted daVinci prostatectomy compared to those who did not. 
The analysis conducted to answer the first question shows a strong association between 
PFMT pre-op and decreased incidence of UI post-op at 6 weeks, 3 months and 12 months 
post-op with the strongest effect being at 6 weeks.  Furthermore, the one single session 
pre-op provided by a physical therapist was sufficient based on the results. 
The analysis conducted to answer the second question failed to identify any factors, 
including PF strength and demographic variables that were associated with less incidence 
of urinary incontinence post-op except for race at 3 months, in that non-whites were more 
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likely to have UI, however this did not affect the relationship between PFMT and 
incontinence.   
The analysis conducted to answer the third question also showed that none of the 
demographics pre-op were related to incontinence post-op, but it did show a trend 
towards a likelihood of not experiencing UI post-op with good  PF strength/endurance, 
less likelihood of UI with fair  PF strength/endurance, and almost certain UI with 
poor  PF strength/endurance at both 6 weeks and 3 months post-op with the relationship 
between PF strength/endurance and incontinence getting stronger over time.   
Finally, the analysis conducted to answer the fourth question show that PF strength and 
endurance improve significantly over time for all men, however more rapidly in those 
who have received the pre-op PFMT.  Incontinence is significantly more likely in men 
who did not receive PFMT at 6 weeks and 3 months with the strongest effect at 6 weeks.  
The functional impact of incontinence also gets smaller over time in both groups, but 
with a significant lesser impact on QoL in the PFMT group.  The impact at 3 months is 
higher in the control group than at 6 weeks in the PFMT group. 
Conclusion 
Therefore, based on the findings of the study and evidence presented this study supports 
the benefits of a pre-op PFMT program.  Prophylactic PFMT could be recommended for 
all patients undergoing RARP and could be part of the guidelines for management of UI 
as a routine pre-op preparation prior to RARP in urology practice.  Giving men who will 
be undergoing RARP confidence pre-op that urine can be controlled post-op would help 
overcome the physical, psychosocial, and emotional problems derived from loss of 
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bladder control.  It would further translate to cost savings for the patients and the 
healthcare system by reducing the total number of PT visits required to achieve 
continence post-op, by reducing the cost of purchase of incontinence products, and/or by 
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Appendix A: Letter of Support 




 Appendix B: Data Collection Form Retrospective 
 
  Data Collection Form Retrospective Study 
                                                         -  Subject # _______ 
                                                         -  Date of surgery _________ 
                                                         -  Group Assignment:  PFMT 
                                                                                           Control 




    
Race/Ethnicity 
 
White Black Hispanic Other 












     
Height (m) 
     
BMI (kg/m²  
     
PSA (ng/ml) 





Gleason Score (2-10) 
     
Clinical T-stage (I-
IV) 
     
PFM Strength (1-5/5) 











Post-op 6 weeks 
 
Post-op 3 months 
 





Bladder neck preserved 
 
Yes No   
NVB preserved 
 
Yes No   
UI 
 
Yes No   
Number of pads/day 
 
    
UI 
 
Yes No   
Number of pads/day 
 
    
UI 
 
Yes No   
Number of pads/day 
 
    
Complications 
 
Yes No   
PT 
 
Yes No   
Intervention 
 
Yes No   
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Appendix C: Informed Consent 
INFORMED CONSENT 
 
Consent Form for Participation in the Research Study entitled: Does one Session of Pre-
operative Pelvic Floor Muscle Training aid in improving Urinary Incontinence 
immediately following Robotic Assisted Radical Prostatectomy: A Retrospective and 
Pilot Study  
Primary Investigator:  
Francine Noel-Ford, PT, DPT, OCS 
7768 Williamson Rd 




Shari Rone-Adams, PT, MHSA, DBA           M. Samuel Cheng, PT, MS,ScD 
3200 South University Drive                          3200 South University Drive 
Ft. Lauderdale, FL 33328                               Ft. Lauderdale, FL 33328 
(954) 262-1740                                               (954)262-1273 
srone@nova.edu                                             mingshun@nova.edu               
                                                                  
Data Collection Sites: 
Back to Basics Family Physical Therapy        Jefferson Surgical Clinic 
7768 Williamson Rd                                       1234 Franklin Rd, SW 
Roanoke, VA 24019                                        Roanoke, VA 24016 
(540)985-0500                                                 (540)283-6000 
 
 
What is the purpose of this study? 
You are invited to be in a research study. The purpose of this research study is to 
determine whether one session of pre-operative pelvic floor muscle training aids in 
improving the symptoms of urinary incontinence immediately following a robotic 
assisted radical prostatectomy.  We will be comparing the results with men who did not 
receive the pre-operative session.  Research studies are designed to gain scientific 
knowledge that may help other people in the future. Your participation is voluntary. 
Please take your time to make your decision, and ask the investigator to explain any 
words or information that you do not understand. You may also discuss the study with 
your physician, friends and family. 
 




Why are you asking me? 
You are being asked to participate in this study because you are a male who will be 
undergoing the robotic assisted radical prostatectomy.  You will be randomly assigned to 
either receive the pre-operative training or not receive the pre-operative training session.  
Men who will not receive the one session training are being asked to participate to be part 
of a control group so we can compare differences in urinary incontinence following the 
surgical intervention between the two groups. 
 
What procedures are involved if I agree to be in the study? 
First, a licensed physical therapist will perform a brief interview to determine if you fit 
the criterion for inclusion in the study. If you meet the study criteria you will then be 
asked to fill out a questionnaire. You will be asked to answer questions about your age, 
occupation, personal health history and some urinary and bladder function specific 
questions. This part of the study will take approximately 15 minutes.  Next, the physical 
therapist will conduct a physical examination which consists of assessing your pelvic 
floor muscle strength and endurance.  The tests that will be used in this examination are 
tests which are routinely used by physical therapists in evaluating the pelvic floor muscle. 
You will be instructed specifically on what you need to do throughout the testing session.  
You will be placed in the side lying position for ease of access and visualization of the 
perineum.  The strength will be assessed through rectal digital palpation.  You will be 
asked to squee e your pelvic floor muscles around the therapist s finger as hard as you 
can by pulling the finger up and in.  Endurance will be tested through the use of a self-
adherent electrode placed on the perineal region between the anus and the scrotum.  The 
electrode is connected to a biofeedback unit which records the activity of the muscle.  For 
the first measure of endurance, you will be asked to contract the pelvic floor muscles as 
hard as possible and to sustain the contraction for up to 10 seconds.   After a 60 seconds 
rest period, the second measure of endurance will be taken.  You will be asked to repeat 
as many strong contractions as possible by contracting the pelvic floor muscles for 2 
seconds and resting for 4 seconds up to 10 contractions.  These measures will take 
approximately 15 min and will allow the therapist to grade your pelvic floor muscle 
strength and endurance.   
 
What are the potential risks and discomfort? 
The risk of harm or discomfort that may happen as a result of taking part in this research 
study is not expected to be more than in daily life or from routine physical or 
psychological examinations or tests.  In healthy adults the risks from performing the 
anticipated tests are remote.  The only foreseeable discomfort would be limited to a 
muscle soreness following the rectal digital examination. This risk will be reduced by 
appropriate handling and detailed instructions to ensure that the test is performed 
correctly.  
If you have any concerns about the risks or benefits of participating in this study, you can 
contact Francine Noel-Ford, PT, DPT, OCS, Shari Rone-Adams, PT, MHSA, DBA, M. 
Samuel Cheng, PT, MS, ScD, or the IRB office at the numbers indicated above. 
 




Are there any benefits to me for taking part in this research study? 
You are not expected to receive any direct benefit from taking part in this research study.  
However, we hope that this research will eventually lead to strategies for preventing the 
severity of urinary incontinence following prostatectomy and that the information learned 
from this study will benefit other people in the future. 
 
What are the costs for participating in this research? 
There are no costs to you if you choose to participate in this research, except for your 
time. 
 
How will you keep my information confidential and private? 
Taking part in this research study may involve providing information that you consider 
confidential or private. Efforts, such as coding research records, keeping research records 
secure and allowing only the authorized researcher to have access to research records, 
will be made to keep your information safe. 
To ensure the privacy and confidentiality of your personal health information, as well as 
information that directly identifies you, the investigator will employ a sequential numeric 
coding system that eliminates the ability to identify you directly from the research 
records.  Access to the computer dataset will be password protected and limited to the 
primary investigator.  All data and reports created as a result of your participation in the 
research study will be entered into the secured computer systems of Back to Basics 
Family Physical Therapy. These will be kept secure, with access to this information 
limited to individuals with proper authority. All information obtained from this study will 
be stored in a locked cabinet in the principle investigators office. All information 
obtained from this study is strictly confidential unless disclosure is required by law. 
 
Use of Protected Health Information (PHI): 
As part of this study, you are asked to authorize Francine Noel-Ford, PT, DPT, OCS, 
Shari Rone-Adams, PT, MHSA, DBA, M. Samuel Cheng, PT, MS, ScD access to your 
personal health information that is related to this study. Examples of your personal health 
information include your health history, how you respond to study test procedures, and 
physical examinations. Your personal health information and information that identifies 
you will not be given to others during or after the study. The purpose of this authorization 
is to allow the researcher to obtain the following specific information to be used as part of 
this research study, to determine the results of the study, to make sure the study is being 
done correctly and to provide required reports.  Any information given would be de-
identified. 
 
You may change your mind and revoke (take back) this authorization at any time, except 
to the extent that the researchers have already acted based on this authorization. 
To revoke this authorization you must write to: 
Francine Noel-Ford, PT, DPT, OCS                                Shari Rone-Adams, PT, MHSA, 
DBA 
7768 Williamson Rd                                    or                3200 South University Drive 
Roanoke, VA 24019                                                         Ft. Lauderdale, FL 33328 
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Refusing to participate or leaving the study will not result in any penalty. If you decide to 
stop participating in the study there are no potential health or safety consequences. The 
investigators also have the right to stop your participation in the study at any time. This 
could be because it is in your best medical interest, your condition worsened, new 
information becomes available, you had an unexpected reaction, or you failed to follow 
instructions. If significant new information relating to the study becomes available which 
may relate to your willingness to continue to participate, this information will be 
provided to you by the investigators. 
You have the right to refuse to sign this authorization and informed consent. This will not 
result in any penalty but you will be unable to participate in the procedures associated 
with this research study. 
You have the right to inspect or copy your Protected Health Information to be used or 
disclosed as permitted under federal and state law (whichever gives you greater access 
rights). Participating in this study does not affect your rights to inspect or copy your 
Protected Health Information. 
 
Can I withdraw or be removed from the study? 
You have the right to refuse to participate or to withdraw at any time, without penalty. If 
you choose to withdraw, your data will not be destroyed and will be kept for the length of 
this study plus three years. Your health information that has already been gathered may 
still be used and disclosed to others. This would be done if it were necessary for the 
research to be reliable. 
 
Voluntary Consent by Participant: 
By signing below, you indicate that 
x this study has been explained to you 
x you have read this document or it has been read to you 
x your questions about this research study have been answered 
x you have been told that you may ask the researchers any study related 
questions in the future or contact them in the event of a research-related 
injury 
x you have been told that you may ask Institutional Review Board (IRB) 
personnel questions about your study rights 
x you are entitled to a copy of this form after you have read and signed it 
x you voluntarily agree to participate in the study entitled Does one Session of 
Pre-operative Pelvic Floor Muscle Training aid in improving Urinary 
Incontinence immediately following Robotic Assisted Radical Prostatectomy: 
A Retrospective and Pilot Study.  
 
Participant's Signature: ___________________________ Date: ________________ 
 
 
Witness's Signature: _____________________________ Date: __________________ 
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Appendix D: Data Collection Form Prospective 
Data Collection Form Prospective Study 
                                                            -  Subject # _______ 
                                                            -  Date to test _________    
                                                            -  Date of surgery _________ 
                                                          Group Assignment:  PFMT 
                                                                                           Control 




    
Race/Ethnicity 
 
White Black Hispanic Other 












     
Height (m) 
     
BMI (kg/m²  
     
PSA (ng/ml) 





Gleason Score (2-10) 
     
Clinical T-stage (I-
IV) 
     
PFM Strength (1-5/5) 










Post-op 6 weeks 
 
Post-op 3 months 
 
 
Bladder neck preserved 
 
Yes No   
NVB preserved 
 
Yes No   
UI 
 
Yes No   
Number of pads/day 
 
    
IIQ-7 
 
    
UCLA-PI 
 
    
PFM Strength (1-5/5)      
PFM Endurance (1-10)  secs reps   
UI 
 
Yes No   
Number of pads/day 
 
    
IIQ-7 
 
    
UCLA-PI 
 
    
PFM Strength (1-5/5)      
PFM Endurance (1-10)  secs reps   
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Appendix E: Hand-outs anatomy/physiology  






























Appendix F: Hand-outs HEP/Bladder Diary 
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            Keeping a Record of Bladder Function 
 
The main purpose of a bladder diary is to document how your bladder functions. A diary 
can give your health care provider an excellent picture of your bladder functions, habits, 
and patterns.  At first, the diary is used as an evaluation tool. Later, it will be used to 
measure your progress on bladder retraining. 
Please complete a bladder diary  and bring it with you to your appointment. 
Your diary will be more accurate if you fill it out as you go through the day.  It can be 
very difficult to remember at the end of the day exactly what happened in the morning. 
Instructions  
Column 1  Time of Day 
The log begins with midnight and covers a 24 hour period.  Afternoon times are bold.  
Select the hour block that corresponds with the time of day you are recording. 
 
Column 2  Type and Amount of Fluid and Food Intake 
 Record the type and amount of fluid you drank 
 Record the type and amount of food you ate 
 Record when you woke up for the day and the hour you went to                       
sleep 
 
Column 3  Amount Voided 
Record the time of day and amount of urine emptied by writing the number of ounces 
voided, marking S for Small amount, M for Medium amount, L for Large amount, or the 
number of seconds taken to void. 
 
Column 4  Amount of leakage 
Record the amount of urine loss at the time it occurred 
     S  Small = drop or two of urine 
     M- Medium = wet underwear 
     L- Large = wet outwear or floor 
 
Column 5  Was Urge Present? 
Describe the urge sensation you had as: 
1- MILD = first sensation of need to go 
2- MODERATE = stronger sensation or need 
3- STRONG = need to get to toilet, move aside! 
 
Column 6  Activity with Leakage/Notes 
Describe the activity associated with the leakage, i.e., coughed, heard running water, 
sneezed, bent over, lifted something, or had a strong urge. 
 
Comments  Special problems and new or changed medications go here. If a pad change 













Appendix G: HEP log 
HOME EXERCISE PROGRAM LOG 
Please complete log daily 
Mark on X in each box as you have completed a set of pelvic floor exercises 




Week # Fast Twitches 
Slow 
Twitches Pelvic Brace 
Day 1 
     
     
Day 2 
     
     
Day 3 
     
     
Day 4 
     
     
Day 5 
     
     
Day 6 
     
     
Day 7 
     






Appendix H: IIQ-7 




Incontinence Impact Questionnaire, Short Form (IIQ-7) 
Has urine leakage affected your: 
  Not at all Slightly Moderately Greatly 
Patient 
Score 
1. Ability to do household chores 
(cooking, housecleaning, laundry)? 0 1 2 3 __ 
2. Physical recreation such as walking, 
swimming, 
or other exercise? 
0 1 2 3 __ 
3. Entertainment activities (movies, 
concerts, etc)? 0 1 2 3 __ 
4. Ability to travel by car or bus more 
than 30 
minutes from home? 
0 1 2 3 __ 
5. Participation in social activities outside 
your 
home? 
0 1 2 3 __ 
6. Emotional health (nervousness, 
depression, 
etc)? 
0 1 2 3 __ 
7. Feeling frustrated? 0 1 2 3 __ 
TOTAL         __ 
            
Scoring.The average score of items responded to is calculated. The average, which 





































































































Appendix J: Copyright permissions 
                                                         
                                             
Dear Francine Noel-Ford 
We hereby grant you permission to reprint the material detailed below at no charge in 
your thesis subject to the following conditions: 
 
1.         If any part of the material to be used (for example, figures) has appeared in our 
publication with credit or acknowledgement to another source, permission must 
also be sought from that source.  If such permission is not obtained then that 
material may not be included in your publication/copies. 
 
2.         Suitable acknowledgment to the source must be made, either as a footnote or in a 
reference list at the end of your publication, as follows: 
 
This article was published in Publication title, Vol number, Author(s), Title of 
article, Page Nos, Copyright Elsevier (or appropriate Society name) (Year).   
 
3.         Your thesis may be submitted to your institution in either print or electronic form. 
 
4.         Reproduction of this material is confined to the purpose for which permission is 
hereby given. 
 
5.         This permission is granted for non-exclusive world English rights only.  For other 
languages please reapply separately for each one required.  Permission excludes 
use in an electronic form other than submission.  Should you have a specific 
electronic project in mind please reapply for permission 
 
6.         This includes permission for UMI to supply single copies, on demand, of the 
complete thesis.  Should your thesis be published commercially, please reapply for 
permission. 
Yours sincerely 
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